User:Colin/ExistingPrices

From Wikipedia, the free encyclopedia

This page contains extracts of cost or price information from 530 drug articles as of 30 Dec 2019.

Abacavir[edit]

The wholesale cost in the developing world as of 2014 is between US$0.36 and US$0.83 per day.[1] As of 2016 the wholesale cost for a typical month of medication in the United States is US$70.50.[2]

  1. ^ "International Drug Price Indicator Guide". ERC. Retrieved 20 November 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 12 December 2016.

Abacavir/lamivudine[edit]

The wholesale cost in the developing world is about US$14.19 to $16.74 per month as of 2014.[1] As of 2015 the cost for a typical month of medication in the United States is more than $200.[2]

  1. ^ "Abacavir + Lamivudine". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ TarasconPP2015, page 59

Abiraterone[edit]

In the United Kingdom it costs the NHS £2,735 a month as of 2018.[1] In the United States this amount costs US$3,276 as of 2019.[2] The medication is marketed widely throughout the world.[3]

Cost[edit]

In the United Kingdom it costs the NHS £2,735 a month as of 2018.[1] In the United States this amount costs US$3,276 as of 2019.[2] A generic version is available in India at a price of US$238 a month as of 2019.[4]

  1. ^ a b BNF76, page 921
  2. ^ a b "Abiraterone Prices, Coupons & Patient Assistance Programs". Drugs.com.
  3. ^ "Abiraterone". Drugs.com.
  4. ^ "PROPOSAL FOR THE INCLUSION OF ENZALUTAMIDE AND ABIRATERONE ACETATE IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES FOR THE TREATMENT OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER" (PDF). p. 22, 25. Retrieved 26 November 2019.

Acetaminophen/butalbital[edit]

In the United States the wholesale cost is about 1.20 USD per dose as of 2019.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Acetazolamide[edit]

The wholesale cost in the developing world is about US$1.40–16.93 per month.[1] In the United States the wholesale cost is about US$125.34 per month.[2]

  1. ^ "Acetazolamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 28 December 2016.

Aciclovir[edit]

The wholesale cost as of 2014 to 2016 was between US$0.03 and US$0.12 for a typical dose by mouth.[1][2] The cost of a typical course of treatment in the United States is less than US$25.[3]

Cost[edit]

The wholesale cost for a 400 mg tablet in March 2016, was between US$0.03 and US$0.12 per dose.[1][2]

  1. ^ a b "Aciclovir". International Drug Price Indicator Guide. Retrieved 6 September 2015.
  2. ^ a b "Pharmacy Pricing". Medicaid. March 2016. Retrieved 8 March 2016.
  3. ^ TarasconPP2015, page 59

Activated charcoal (medication)[edit]

The wholesale costs in the developing world is between US$0.46 and US$0.86 per dose.[1] In the United States a course of treatment costs less than US$25.[2]

  1. ^ "Charcoal, Activated". International Drug Price Indicator Guide. Retrieved 13 August 2015.
  2. ^ TarasconPP2015, page 469

Adalimumab[edit]

A month supply in the United Kingdom costs the NHS about £704.28 as of 2018.[1] In the United States the wholesale cost of this amount is about US$5,041.12.[2] In 2014, a biosimilar came to market in India at a price of US$400 per month.[3]

  1. ^ BNF76, page 1074
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "India's Cadila launches first cheaper copy of world's top-selling drug". Reuters. 9 December 2014. Retrieved 19 March 2019.

Albendazole[edit]

The wholesale cost in the developing world is between 0.01 and US$0.06 per dose.[1] In the United States, as of 2019, the wholesale cost is about US$128 per dose.[2]

Cost[edit]

In many areas of the world it costs between US$0.01 and US$0.06 per dose.[1] In the United States, however, it costs about US$50 per dose, as of 2014.[3] In Raleigh, North Carolina, the brand-name prescription cost was around US$800, and US$540 for the generic. The pharmaceutical company Amedra increased the price after purchasing the rights to the drug, instead of lowering it as generics are predicted to do, drawing criticism from patients' rights advocates and US Democratic Party leaders.[4]

  1. ^ a b "Albendazole". International Drug Price Indicator Guide. Retrieved August 18, 2015.
  2. ^ "NADAC as of 2019-06-05 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 10 June 2019.
  3. ^ TarasconPP2014, page 40
  4. ^ Greene, Jeremey A. (2015-09-23). "Generic drug price gouging: How Shkreli and other monopolists cornered the market on essential medications". Slate.

Alcohols (medicine)[edit]

The wholesale cost in the developing world is about US$1.80–9.50 per litre of 70% denatured ethanol.[1] In the United Kingdom it costs the NHS about 3.90 GBP per liter of 99% denatured alcohol.[2]

  1. ^ "Alcohol, Denatured". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 42, 838

Alendronic acid[edit]

In the United Kingdom, a month of medication costs the NHS about 0.41 pounds as of 2019.[1] In the United States, the wholesale cost is about US$1.16 per month.[2]

  1. ^ BNF76, pages 710–711
  2. ^ "NADAC as of 2019-01-30". Centers for Medicare and Medicaid Services. Retrieved 2 February 2019.

Allopurinol[edit]

The wholesale cost in the developing world is about US$0.81–3.42 per month.[1] In the United States a month of treatment costs less than $25.[2]

  1. ^ "Allopurinol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 465

Alprazolam[edit]

The wholesale cost in the United States is less than US$0.03 per dose as of 2018.[1] In 2016, it was the 19th most prescribed medication in the United States, with more than 27 million prescriptions.[2]

  1. ^ "NADAC as of 2018-10-24". Centers for Medicare and Medicaid Services. Retrieved 26 October 2018.
  2. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Alteplase[edit]

In the United Kingdom it costs about £864 per treatment as of 2018.[1] In the United States this amount costs about US$9,197 as of 2019.[2]

Society and culture[edit]

In the United Kingdom it costs about £864 per treatment as of 2018.Cite error: The <ref> tag has too many names (see the help page). In the United States this amount costs about US$9,197.[2]

  1. ^ BNF76, page 216
  2. ^ a b "Activase Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 12 November 2019.

Amikacin[edit]

The wholesale cost in the developing world is 13.80 to US$130.50 for a month.[1] In the United States a typical course of treatment costs 25 to US$50.[2]

  1. ^ "Amikacin Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 35

Amiodarone[edit]

In the developing world the wholesale cost as of 2014 is about US$0.06–0.26 per day.[1] In the United States a typical month supply is between $100 and $200.[2]

  1. ^ "Amiodarone". International Drug Price Indicator Guide. Retrieved 22 August 2016.
  2. ^ TarasconPP2015, page 124

Amitriptyline[edit]

The wholesale cost in the developing world as of 2014 was between 0.01 and US$0.04 per dose.[1] In the United States, it costs about US$0.20 per dose.[2]

  1. ^ "Amitriptyline". International Drug Price Indicator Guide. Retrieved 2 December 2015.
  2. ^ "Amitriptyline Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 25 September 2014.

Amlodipine[edit]

Wholesale cost in the developing world is US$0.003 to 0.066 per day for a typical dose as of 2015.[1] In the United States, a month's supply costs less than $25.[2]

  1. ^ "Amlodipine". International Drug Price Indicator Guide. Retrieved 23 July 2016.
  2. ^ TarasconPP2015, page 154

Amlodipine/benazepril[edit]

A month supply in the United States has a wholesale cost of about US$4.50.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Amodiaquine[edit]

The wholesale cost is about US$0.01 per dose as of 2014.[1]

  1. ^ "Amodiaquine". International Drug Price Indicator Guide. Retrieved 4 December 2015.

Amoxicillin[edit]

It has a wholesale cost in the developing world of between US$0.02 and $0.05 per pill.[1] In the United States, ten days of treatment costs about US$16 ($0.40 per pill).[2]

  1. ^ "Amoxicillin". International Drug Price Indicator Guide. Retrieved 1 August 2015.
  2. ^ "Amoxicillin". The American Society of Health-System Pharmacists. Retrieved 1 August 2015.

Amoxicillin/clavulanic acid[edit]

The wholesale cost in the developing world is about US$0.18–1.14 per day.[1] In the United States a course of treatment costs $50–100.[2]

  1. ^ "Amoxicillin + Clavulanic Acid". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 97

Ampicillin[edit]

Its wholesale cost in the developing world is between US$0.13 and 1.20 for a vial of the intravenous solution as of 2014.[1] In the United States, it is available as a generic medication and 10 days of treatment cost about $13.[2]

Cost[edit]

As of 2014, ampicillin's wholesale cost is between US$0.13 and 1.20 for a vial of the intravenous solution.[1] In the United States, it is available as a generic medication: 10 days of treatment cost about $13.[2]

  1. ^ a b "Ampicillin". International Drug Price Indicator Guide. Retrieved 1 August 2015.
  2. ^ a b "Ampicillin". The American Society of Health-System Pharmacists. Retrieved 1 August 2015.

Anastrozole[edit]

The wholesale cost in the developing world is about US$1.92–30.60 a month.[1] In the United States the wholesale cost is about $3.81 per month.[2]

  1. ^ "Anastrozole". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 18 December 2016.

Anti-tetanus immunoglobulin[edit]

The wholesale cost in the developing world for the horse version is about US$0.90–3.60 per 1500 iu vial, while the human version is US$10.00–46.86 for 250 iu.[1][2][3] In the United States a course of treatment costs about $100–200.[4]

  1. ^ "Tetanus Antitoxin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Immunoglobulin Prices 2013 - PAHO/WHO". PAHO. Retrieved 8 January 2017.
  3. ^ "Immunoglobulin, Anti-Tetanus". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  4. ^ TarasconPP2015, page 320

Antivenom[edit]

Depending on the type, the wholesale cost in the developing world is US$9.00–US$118.80 per vial.[1] In the United States, the wholesale cost is as high as $2,300 per dose.[2][3]

  1. ^ "Antivenom Serum". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ Lewis, Danny (11 September 2015). "Why A Single Vial Of Antivenom Can Cost $14,000". Smithsonian. Retrieved 9 January 2017.
  3. ^ "One step closer to cheaper antivenom". ScienceDaily. 3 September 2015. Retrieved 9 January 2017.

Apixaban[edit]

A month supply in the United Kingdom costs the NHS about £57 as of 2019.[1] In the United States the wholesale cost of this amount is about $427.[2]

  1. ^ BNF76, pages 124-125
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Aprepitant[edit]

In the United States it about US$230 per dose.[1] This amount in the United Kingdom cost the NHS about £16.[2]

  1. ^ "Emend Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 13 October 2019.
  2. ^ "Aprepitant | Medicinal forms | BNFc content published by NICE". webcache.googleusercontent.com. NICE. Retrieved 13 October 2019.

Aripiprazole[edit]

In the United Kingdom, a month's supply costs the NHS about £2.75 as of 2019.[1] In the United States, the wholesale cost of this amount is 10 USD.[2]

  1. ^ BNF76, page 392
  2. ^ "NADAC as of 2019-02-20". Centers for Medicare and Medicaid Services. Retrieved 26 February 2019.

Arsenic trioxide[edit]

In the United Kingdom it costs the NHS £292 a dose as of 2018.[1] In the United States this amount costs about US$508 as of 2019.[2]

Cost[edit]

In the United Kingdom it costs the NHS £292 a dose as of 2018.[1] In the United States this amount costs about US$508 as of 2019. With initial treatment being 60 days the cost for a course of treatment is £17,520 and US$30,000 respectively.

  1. ^ a b BNF76, page 907
  2. ^ "Arsenic trioxide Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 16 November 2019.

Artemether[edit]

The wholesale cost in the developing world is between US$0.38 and US$16.47 per vial.[1] The combination form costs between US$100 and US$200 for a course of treatment in the United States.[2]

  1. ^ "Artemether". International Drug Price Indicator Guide. Retrieved 1 January 2016.
  2. ^ TarasconPP2015, page 45

Artemether/lumefantrine[edit]

The wholesale cost in the developing world is between US$0.10 and US$1.2 per day as of 2014.[1] It is not available as a generic medication and a course of treatment costs between US$100 and US$200 in the United States.[2]

  1. ^ "Artemether + Lumefantrine". International Drug Price Indicator Guide. Retrieved 4 December 2015.[permanent dead link]
  2. ^ TarasconPP2015, page 45

Artesunate[edit]

The wholesale cost in the developing world is US$2.09 to US$2.57 a dose.[1]

  1. ^ "Artesunate". International Drug Price Indicator Guide. Retrieved 1 January 2016.

Artesunate/amodiaquine[edit]

The wholesale cost in the developing world is about US$0.85 to US$1.52 for a course of treatment.[1]

  1. ^ "Artesunate + Amodiaquine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Asparaginase[edit]

The wholesale cost in the developing world is about US$42.00 per 10,000 IU vial.[1] This amount in the United Kingdom costs the NHS 613.00 pounds.[2]

  1. ^ "Asparaginase". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 600

Aspirin[edit]

As of 2014, the wholesale cost in the developing world is US$0.002 to US$0.025 per dose.[1] As of 2015, the cost for a typical month of medication in the United States is less than US$25.00.[2]

  1. ^ "Acetylsalicylic Acid". International Drug Price Indicator Guide. Retrieved 30 August 2016.
  2. ^ TarasconPP2015, page 5

Atazanavir[edit]

The wholesale cost in the developing world is about US$15.72 per month.[1] As of 2015, the cost for a typical month of medication in the United States was more than $200.[2]

  1. ^ "Atazanavir". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ TarasconPP2015, page 67

Atenolol[edit]

Atenolol was patented in 1969 and approved for medical use in 1975.[1] It is available as a generic medication.[2] In the United States, the wholesale cost per month is less than 15 USD as of 2018.[3] In the United Kingdom, a month of treatment costs the NHS less than 5 pounds.[4]

  1. ^ Fischer, Janos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 461. ISBN 9783527607495.
  2. ^ "Atenolol Monograph for Professionals". Drugs.com. AHFS. Retrieved 23 December 2018.
  3. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  4. ^ BNF76, pages 151–153

Atenolol/chlorthalidone[edit]

A month supply in the United Kingdom costs the NHS less than 2 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.30.[2]

  1. ^ BNF76, page 153
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Atomoxetine[edit]

A month's supply in the United Kingdom costs the NHS about £53 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$77.[2]

  1. ^ BNF76, pages 344–345
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Atorvastatin[edit]

In the United States, the wholesale cost per month is about 3.80 USD as of 2018.[1] In the United Kingdom, it costs the NHS about £0.70 per month as of 2018.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, pages 200–201

Atovaquone/proguanil[edit]

In the United Kingdom it costs £2.10 per dose as of 2019.[1] The wholesale cost in the United States is $US 2.82 per dose as of 2019.[2]

  1. ^ BNF76, page 604
  2. ^ "NADAC as of 2019-09-11 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 12 September 2019.

Atracurium besilate[edit]

The wholesale cost in the developing world is about US$1.69–1.87 per dose.[1]

  1. ^ "Atracurium". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Atropine[edit]

It is available as a generic medication and is not very expensive.[1][2] A one-milligram vial costs between US$0.06 and US$0.44, wholesale, in the developing world.[3]

  1. ^ "Atropine". The American Society of Health-System Pharmacists. Retrieved Aug 13, 2015.
  2. ^ TarasconPP2014, page 386
  3. ^ "Atropine Sulfate". International Drug Price Indicator Guide. Retrieved 13 August 2015.

Atropine/diphenoxylate[edit]

In the United States the wholesale cost per is dose is US$0.31.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Azathioprine[edit]

The wholesale cost in the developing world is about US$7.63–17.19 a month.[1] The wholesale cost in the United States is about US$35.34 per month.[2]

  1. ^ "Azathioprine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 20 December 2016.

Azelastine[edit]

A 22 millilitre bottle in the United Kingdom costs the NHS about £10.50 as of 2019.[1] In the United States the wholesale cost of this amount is about US$8.40.[2]

  1. ^ BNF76, page 1169
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Azithromycin[edit]

The wholesale cost in the developing world is about US$0.18 to US$2.98 per dose.[1] In the United States, it is about US$4 for a course of treatment as of 2018.[2]

Cost[edit]

The wholesale cost is about US$0.18 to US$2.98 per dose.[1] In the United States it is about US$4 for a course of treatment as of 2018.[2] In India it is about US$1.7 for a course of treatment

  1. ^ a b "Azithromycin". International Drug Price Indicator Guide. Retrieved 4 September 2015.
  2. ^ a b "NADAC as of 2018-05-23". Centers for Medicare and Medicaid Services. Retrieved 24 May 2018.

BCG vaccine[edit]

Between 2011 and 2014 the wholesale price was US$0.16 to US$1.11 a dose in the developing world.[1][2] In the United States it costs US$100 to US$200.[3]

  1. ^ "Vaccine, Bcg". International Drug Price Indicator Guide. Retrieved 6 December 2015.[permanent dead link]
  2. ^ "Vaccine, Bcg". ERC. Retrieved 13 June 2016.
  3. ^ TarasconPP2015, page 312

Baclofen[edit]

A month supply in the United Kingdom costs the NHS about £1 as of 2019.[1] In the United States the wholesale cost of this amount is about US$8.40.[2]

  1. ^ BNF76, page 1092
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Barium sulfate suspension[edit]

The wholesale cost in the developing world is about US$37.80–79.33 per kilogram.[1] In the United States a course of treatment is not very expensive.[2]

  1. ^ "Barium Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 171

Beclometasone[edit]

The wholesale price in the developing world for an inhaler containing 200 doses of medication is about US$3.20 as of 2014.[1] In the United States it costs US$50–100 for a typical month supply of the inhaled form.[2]

  1. ^ "Beclometasone". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 451

Benazepril[edit]

A month supply in the United States costs about US$1.32 as of 2019.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Benzathine benzylpenicillin[edit]

The wholesale cost in the developing world is about 0.27 to 1.71 USD for a course of treatment.[1] In the United States the medication costs 50 to 100 USD for a dose as of 2015.[2] In the United Kingdom it costs the NHS about 0.95 to 1.89 pounds a dose as of 2015.[3]

  1. ^ "Penicillin, Benzathine Benzyl". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 94
  3. ^ BNF 69, page 367

Benzatropine[edit]

In the United States the wholesale cost is about 6 USD per month.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Benzonatate[edit]

In the United States the wholesale cost of is about 0.12 USD per dose.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Benzoyl peroxide/clindamycin[edit]

Currently Duac costs $362.69 for 45 grams in the US (significantly less elsewhere, eg. $15 for 60 grams in Poland[1]) and Onexton costs $477.74 for 50 grams.[2][3]

  1. ^ "Duac żel(10 mg/g+50 mg/g) - tuba 60 g - wyszukiwarka i baza leków - Indeks24.pl". indeks24.pl (in Polish). Retrieved 2019-08-13.
  2. ^ "Duac Prices, Coupons & Patient Assistance Programs - Drugs.com". www.drugs.com. Retrieved 2016-11-19.
  3. ^ "Onexton Prices, Coupons & Patient Assistance Programs - Drugs.com". www.drugs.com. Retrieved 2016-11-19.

Benzyl benzoate[edit]

The wholesale cost in the developing world is about US$0.21–0.53 per 100 mL.[1] In the United Kingdom it costs the NHS about £2.50 for 500 mL.[2]

  1. ^ "Benzyl Benzoate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 836

Benzylpenicillin[edit]

The wholesale cost in the developing world is about US$0.24–2.72 per day.[1] In the United States a course of treatment costs $100–200.[2]

  1. ^ "Penicillin, Benzyl". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 95

Bevacizumab[edit]

The wholesale cost in the developing world is about US$638.54 per vial.[1] This dose in the United Kingdom cost the NHS about £242.66 in 2015.[2]

Costs[edit]

In countries with national health care systems (such as the UK and Canada), many of those national health services have restricted bevacizumab on the basis of cost-benefit calculations; in the U.K., for example, the National Institute for Health and Care Excellence has taken the position that bevacizumab should not be funded by the NHS because it costs nearly £21,000 per patient but only minimal benefit in many cancers.[3] In 2006, the Scottish Medicines Consortium recommended against the NHS funding Avastin for first-line treatment of metastatic carcinoma of the colon or rectum, due to estimated costs of £24,000 to £93,000 per quality-adjusted life year (QALY).[4] The addition of bevacizumab to standard treatment can prolong the lives of lung cancer patients by several months, at a cost of $100,000 a year in the United States.[5] For colorectal cancer, Robert J. Mayer wrote in the New England Journal of Medicine that bevacizumab extended life by 4.7 months (20.3 months vs. 15.6 months) in the initial study, at a cost of $42,800 to $55,000.[6] Costs in other countries vary; in Canada it is reported to cost $40,000 CAD per year.[7] On September 16, 2014 Genentech reclassified bevacizumab as a specialty drug which are only available through specialty pharmacies. "Specialty drugs usually fall under the FDA’s Risk Evaluation and Mitigation Strategy (REMS) program, established for compounds like the testosterone... that may have unusual side effects; or for drugs that are unusually expensive."[8] This has caused concern to hospitals as the price increased.[8] According to IMS Health, the average price charged by hospitals for bevacizumab is approximately $9000 compared to approximately $2300 when administered in a doctor's office. As a result of the new distribution arrangement, many hospitals will no longer be eligible for the 51% discount to average wholesale price that was mandated by the Affordable Healthcare Act under the old distribution arrangement.[9] When bevacizumab is used in the treatment of wet age-related macular degeneration (wet AMD), only tiny and relatively inexpensive doses (compared to amounts used in colon and other cancers) are required. Some investigators reported in 2010 that bevacizumab at a cost of around $42 a dose is as effective as ranibizumab at a cost of over $1,593 a dose.[10][11]

  1. ^ "Bevacizumab". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 597
  3. ^ Briggs, Helen (BBC News Health Reporter) (August 24, 2010). "Critics condemn bowel cancer drug rejection". Retrieved 2010-08-24.
  4. ^ "Bevacizumab" (PDF). Scottish Medicines. Retrieved 18 July 2012.
  5. ^ Berenson, Alex (February 15, 2006). "A Cancer Drug Shows Promise, at a Price That Many Can't Pay". The New York Times.
  6. ^ Mayer RJ (June 2004). "Two steps forward in the treatment of colorectal cancer". The New England Journal of Medicine. 350 (23): 2406–8. doi:10.1056/NEJMe048098. PMID 15175443.
  7. ^ "P.E.I. sole holdout on cancer drug". CBC News. November 26, 2009.
  8. ^ a b Saporito, Bill (27 October 2014). "Hospitals Furious at Cancer-Drug Price Hikes". Time. Retrieved 26 October 2015.
  9. ^ "Innovation in Cancer Care and Implications for Health Systems: Global Oncology Trend Report | Reports".
  10. ^ Mundy, Alicia (June 17, 2010). "Medicare Eye Study Finds Untapped Savings". Wall Street Journal.
  11. ^ Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W (June 2010). "Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study". BMJ. 340: c2459. doi:10.1136/bmj.c2459. PMID 20538634.

Bicalutamide[edit]

The wholesale cost in the developing world is about US$7.07 to US$144.22 per month.[1] In the United States it costs about US$10 and above per month.[2]

Cost and generics[edit]

Bicalutamide is off-patent and available as a generic, and its cost is low in comparison to a number of other similar medications (from US$10 to US$15.44 for a 30-day supply of once-daily 50 mg tablets).[3][2] Brand name Casodex costs US$556.17 for a 30-day supply of once-daily 50 mg tablets as of 2017.[4] Unlike bicalutamide, the newer NSAA enzalutamide is still on-patent, and for this reason, is considerably more expensive in comparison (US$7,450 for a 30-day supply as of 2015).[5] Bicalutamide is considerably less costly than GnRH analogues, which, in spite of some having been off-patent many years, have been reported (in 2013) to typically cost US$10,000–$15,000 per year (or about US$1,000 per month) of treatment.[6][7]

  1. ^ "Bicalutamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ a b "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 17 January 2017.
  3. ^ "Bicalutamide Prices, Coupons and Patient Assistance Programs". Drugs.com. Retrieved 31 August 2015.
  4. ^ "Casodex Prices, Coupons and Patient Assistance Programs". Drugs.com.
  5. ^ Ramadan WH, Kabbara WK, Al Basiouni Al Masri HS (2015). "Enzalutamide for patients with metastatic castration-resistant prostate cancer". OncoTargets and Therapy. 8: 871–6. doi:10.2147/OTT.S80488. PMC 4407758. PMID 25945058.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Emans SJ, Laufer MR (5 January 2012). Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology. Lippincott Williams & Wilkins. pp. 365–. ISBN 978-1-4511-5406-1. Therapy with GnRH analogs is expensive and requires intramuscular injections of depot formulations, the insert of a subcutaneous implant yearly, or, much less commonly, daily subcutaneous injections.
  7. ^ Hillard PJ (29 March 2013). Practical Pediatric and Adolescent Gynecology. John Wiley & Sons. pp. 182–. ISBN 978-1-118-53857-9. Treatment is expensive, with costs typicall in the range of $10,000–$15,000 per year.

Bimatoprost[edit]

A 3 milliliter bottle in the United Kingdom costs the NHS about 9.30 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$80.[2]

  1. ^ BNF76, page 1149
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare & Medicaid Services (CMS). Retrieved 3 March 2019.

Biperiden[edit]

The wholesale cost in the developing world is about US$1.52–12.92 per month.[1] In the United States it costs about $50–100 per month.[2]

  1. ^ "Biperiden". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 340

Bisoprolol[edit]

The wholesale cost in the developing world is about US$2.98–4.94 per month.[1] In the United States, as of 2015, it costs about $25–50 a month.[2]

  1. ^ "Bisoprolol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 151

Bleomycin[edit]

The wholesale cost in the developing world is between US$14 and US$78 a dose.[1]

  1. ^ "Bleomycin". International Drug Price Indicator Guide. Retrieved 26 August 2015.

Bortezomib[edit]

In the United States it costs US$1,360 per 3.5 mg vial.[1] In the United Kingdom this amount costs the NHS £762 such that a course of treatment is about £12,261 as of 2014.[2]

Costs[edit]

In the UK, NICE initially recommended against Velcade in October 2006 due to its cost of about £18,000 per person, and because studies reviewed by NICE reported that it could only extend the life expectancy by an average of six months over standard treatment.[3] However, the company later proposed a performance-linked cost reduction for multiple myeloma,[4] and this was accepted.[5]

  1. ^ "Bortezomib Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 13 October 2019.
  2. ^ "Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation". NICE. February 2014. p. 2. Retrieved 13 October 2019.
  3. ^ "NHS watchdog rejects cancer drug". BBC News UK. 2006-10-20. Retrieved 2009-08-14.
  4. ^ "Summary of VELCADE Response Scheme" (PDF). Retrieved 2009-08-14.
  5. ^ "More Velcade-Style Risk-Sharing In The UK?". Euro Pharma Today. 2009-01-21. Retrieved 2009-08-14.

Bremelanotide[edit]

In the United States it is sold for US$948 per dose as of 2019.[1]

  1. ^ "Vyleesi Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 21 November 2019.

Brimonidine[edit]

One milliliter in the United Kingdom costs the NHS about 1.13 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$0.60.[2]

  1. ^ BNF76, page 1153
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Budesonide[edit]

The wholesale price in the developing world for an inhaler containing 200 doses is about US$5 to US$7 as of 2014.[1] As of 2015 the cost for a typical month of the inhaler medication in the United States is US$100 to US$200.[2] In 2016 it was the 207th most prescribed medication in the United States with more than 2 million prescriptions.[3]

  1. ^ "Budesonide". International Drug Price Indicator Guide. Retrieved 5 December 2015.
  2. ^ TarasconPP2015, page 451
  3. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Budesonide/formoterol[edit]

In the United States, as of 2017, the wholesale cost of an inhaler is about 30 USD.[1] In the United Kingdom the cost as of 2015 was about 35 pounds for a unit with 120 doses.[2]

  1. ^ "NADAC as of 2017-12-13". Centers for Medicare and Medicaid Services. Retrieved 13 December 2017.
  2. ^ BNF69, page 202

Bumetanide[edit]

A month supply in the United Kingdom costs the NHS about 1.20 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.[2]

  1. ^ BNF76, pages 225–226
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Bupivacaine[edit]

Bupivacaine is available as a generic medication and is not very expensive.[1][2] The wholesale cost in the developing world of a vial is about US$2.10.[3]

Cost[edit]

Bupivacaine is available as a generic medication and is not very expensive.[1][4] The wholesale cost of a vial of bupivacaine is about US$2.10.[3]

  1. ^ a b "Bupivacaine Hydrochloride". The American Society of Health-System Pharmacists. Retrieved Aug 1, 2015.
  2. ^ TarasconPP2015, page 22
  3. ^ a b "Bupivacaine HCL". International Drug Price Indicator Guide. Retrieved 29 August 2015.
  4. ^ TarasconPP2015, page 22

Buprenorphine[edit]

For the tablets the wholesale cost in the United States is between US$0.86 and US$1.32 per daily dose as of 2017.[1]

  1. ^ "NADAC as of 2017-11-29". Centers for Medicare and Medicaid Services. Retrieved 3 December 2017.

Buprenorphine/naloxone[edit]

In the United States the wholesale cost as of 2017 is between US$2.32 and US$3.15 per day.[1] In the United Kingdom a similar dose costs the NHS £0.90 to £2.72 per day, according to 2015 data.[2]

Cost[edit]

In the United States the wholesale cost as of 2017 is between US$2.32 and US$3.15 per day.[1] In the United Kingdom a similar dose costs the NHS £0.90 to £2.72 per day, according to 2015 data.[2]

  1. ^ a b "NADAC as of 2017-11-29". Centers for Medicare and Medicaid Services. Retrieved 3 December 2017.
  2. ^ a b BNF69, page 346

Bupropion[edit]

In the United States the wholesale cost per dose is less than US$0.50 as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Buspirone[edit]

A month supply in the United Kingdom costs the NHS about 10 GBP as of 2019.[1] In the United States the wholesale cost of this amount is about 2.65 USD.[2]

  1. ^ BNF76, page 338
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Calamine[edit]

The wholesale cost in the developing world is about US$0.25–3.85 per 100-ml bottle.[1] In the United Kingdom, it costs the National Health Service about £0.44.[2]

  1. ^ "Calamine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 801

Calcium gluconate[edit]

The wholesale cost in the developing world is about US$0.21–1.34 per one-gram vial, 10 ml of 100 mg/ml (10% solution).[1] In the United Kingdom this amount costs the NHS about 0.65 pounds.[2]

  1. ^ "Calcium Gluconate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 680, 694

Calcium supplement[edit]

The wholesale cost in the developing world is about US$0.92–4.76 per month.[1] In the United States treatment generally costs less than $25 per month.[2]

  1. ^ "Calcium Lactate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, pages 215–216

Canagliflozin[edit]

A month's supply in the United Kingdom costs the NHS about £39.20 as of 2019.[1] In the United States the wholesale cost of this amount is about US$475.20.[2]

  1. ^ BNF76, page 687
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Canakinumab[edit]

One 150 mg subcutaneous injection, usually needed every two weeks, costs over $16,700; discounts are sometimes available.[1]

  1. ^ https://www.drugs.com/price-guide/ilaris

Capecitabine[edit]

The wholesale cost in the developing world is about US$122.64–195.66 per cycle of medication.[1] In the United Kingdom it costs the NHS about £210.67 per cycle.[2] In the United States it costs about $1,892.00 as of 2016.[3]

  1. ^ "Capecitabine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 585, 588
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 19 December 2016.

Capreomycin[edit]

The wholesale cost in the developing world is about 6.25 to 8.98 USD a dose.[1]

  1. ^ "Capreomycin". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Carbamazepine[edit]

The wholesale cost in the developing world is about US$0.07 to US$0.24 per day as of 2015.[1]

  1. ^ "Carbamazepine". International Medical Products Price Guide. Retrieved 26 November 2019.

Carbidopa/levodopa[edit]

The wholesale price in the developing world is about US$1.80 to $3.00 a month.[1] In the United States, a month's supply costs about $50 to $150.[2]

Cost[edit]

It is available as a generic medication and is moderately expensive.[3] Globally, the wholesale price of the medication is about US$1.80 to $3.00 a month.[1] In the United States a month's supply is about $50 to $150.[2]

  1. ^ a b "Levodopa + Carbidopa". International Drug Price Indicator Guide. Retrieved 22 August 2015.
  2. ^ a b "Levodopa/Carbidopa". The American Society of Health-System Pharmacists. Retrieved Aug 21, 2015.
  3. ^ TarasconPP2013, page 303

Carboplatin[edit]

The wholesale cost in the developing world is about US$26.49–37.37 per 450 mg vial.[1] In the United Kingdom it costs the National Health Service (NHS) about 160 pounds (around US$200).[2]

  1. ^ "Carboplatin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 605

Carisoprodol[edit]

In the United States the wholesale cost is less than US$0.10 per dose.[1]

  1. ^ "NADAC as of 2019-02-27 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 8 April 2019.

Carvedilol[edit]

In the United States, the wholesale cost per dose is less than 0.05 USD as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Cefalexin[edit]

Generic drug versions are available under other trade names and are inexpensive.[1][2]

Cost[edit]

A seven day course of cephalexin costs a consumer about CA$25 in Canada in 2014.[3] The wholesale cost of this amount is about CA$4.76 as of 2019.[4] In the United States this amount costs a consumer about US$20.96 as of 2019.[5] In Australia a course of treatment costs at most AU$26.77 as of 2019.[6] The wholesale price in the developing world is about US$2.18 as of 2015.[7]

  1. ^ "Cephalexin". The American Society of Health-System Pharmacists. Retrieved Apr 21, 2014.
  2. ^ Hanlon, Geoffrey; Hodges, Norman (2012). Essential Microbiology for Pharmacy and Pharmaceutical Science. Hoboken: Wiley. p. 140. ISBN 9781118432433.
  3. ^ "Price Comparison of Commonly Prescribed Pharmaceuticals in Alberta 2014" (PDF). Retrieved 25 November 2019.
  4. ^ "Online Formulary 2019". formulary.drugplan.health.gov.sk.ca. Retrieved 25 November 2019.
  5. ^ "Cephalexin Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 25 November 2019.
  6. ^ Health, Australian Government Department of. "Pharmaceutical Benefits Scheme (PBS) |". Australian Government Department of Health. Retrieved 25 November 2019.
  7. ^ "Search Results By Name | International Medical Products Price Guide". The International Medical Products Price Guide. Retrieved 25 November 2019.

Cefdinir[edit]

In the United States the wholesale cost of ten days of medication is about US$9.40.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Cefixime[edit]

The wholesale cost in the developing world is about US$0.26–2.09 per dose.[1] In the United States a course of treatment costs about $100–200 as of 2015.[2]

  1. ^ "Cefixime". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 86

Cefotaxime[edit]

The wholesale cost in the developing world is about US$0.23–4.70 per dose.[1] In the United States a course of treatment costs $100–200.[2]

  1. ^ "Cefotaxime". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 87

Ceftazidime[edit]

The wholesale cost in the developing world is about US$2.84–16.76 per day.[1] In the United States a course of treatment costs $100–200.[2]

  1. ^ "Ceftazidime". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 87

Ceftriaxone[edit]

In the developed world the wholesale cost per dose is about US$0.20 to US$2.32 as of 2014.[1] In the United States a course of treatment is typically less than US$25.[2]

  1. ^ "Ceftriaxone". International Drug Price Indicator Guide. Retrieved 29 August 2016.
  2. ^ TarasconPP2014, page 75

Cefuroxime[edit]

A week of treatment when taken by mouth in the United Kingdom costs the NHS about £18 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$8.50.[2]

  1. ^ BNF76, page 518
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Celecoxib[edit]

A month supply in the United Kingdom costs the NHS less than £2 as of 2019.[1] In the United States, the wholesale cost of this amount is about $US12.90.[2]

  1. ^ BNF 76, pages 1097–1098
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ceritinib[edit]

Cost[edit]

As of 2019, Zykadia is priced at US$8,578 per bottle of 70 capsules.[1]

  1. ^ "Zykadia Prices". Drugs.com. Retrieved 27 August 2019.

Cetirizine[edit]

A month's supply in the United Kingdom costs the NHS about £0.70 as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.50.[2]

  1. ^ BNF76, page 279
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Chlorambucil[edit]

The wholesale cost in the developing world is about US$111.87 per month.[1] In the United Kingdom it costs the NHS about £145.84 per month.[2]

  1. ^ "Chlorambucil". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 580

Chloramphenicol[edit]

The wholesale cost in the developing world of an intravenous dose is about US$0.40–1.90.[1] In the United States an intravenous dose costs about $41.47.[2]

Cost[edit]

In many areas of the world an intravenous dose is about US$0.40–1.90.[1] In the United States it costs about $3.60 per dose in oral tablet form at wholesale. It is the cheapest treatment available for meningitis (US$5 per treatment course, compared to US$30 for ampicillin and US$15 for five days of ceftriaxone). It has the great advantage of requiring only a single injection, whereas ceftriaxone is traditionally given daily for five days. This recommendation may yet change, now that a single dose of ceftriaxone (cost US$3) has been shown to be equivalent to one dose of oily chloramphenicol.[3]

  1. ^ a b "Chloramphenicol". International Drug Price Indicator Guide. Retrieved 26 August 2015.
  2. ^ "Chloramphenicol Prices, Coupons & Patient Assistance Programs - Drugs.com". Drugs.com.
  3. ^ Nathan, N.; Borel, T.; Djibo, A. (2005). "Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study" (PDF). Lancet. 366 (9482): 308–313. doi:10.1016/S0140-6736(05)66792-X. hdl:10144/23232. PMID 16039333.

Chlorhexidine[edit]

The wholesale cost in the developing world is about US$2.20–4.10 per liter of 5% solution.[1] In the United Kingdom this amount costs the NHS about £4.80.[2]

  1. ^ "Chlorhexidine Gluconate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 568, 791, 839

Chlorine-releasing compounds[edit]

The wholesale cost in the developing world is about US$0.01–0.02 per 500 mg of the chloramine type.[1] They are used extensively in both the medical and the food industry.[2]

Disinfectants[edit]

They are easy to use, widely available, and very cheap: as of 2014, the wholesale cost of chloramine-T in the developing world was US$0.01–0.02 per 500 mg tablet.[1]

  1. ^ a b "Chloramine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ Block, Seymour Stanton (2001). Disinfection, Sterilization, and Preservation. Lippincott Williams & Wilkins. p. 1082. ISBN 9780683307405.

Chloroquine[edit]

The wholesale cost in the developing world is about US$0.04.[1] In the United States, it costs about US$5.30 per dose.[2]

  1. ^ "Chloroquine (Base)". International Drug Price Indicator Guide. Retrieved 4 December 2015.
  2. ^ "Aralen Phosphate". The American Society of Health-System Pharmacists. Retrieved 2 December 2015.

Chloroxylenol[edit]

The wholesale cost in the developing world is about US$2.00–6.20 per litre of 5% solution.[1]

  1. ^ "Chloroxylenol". International Drug Price Indicator Guide. Retrieved 8 December 2016.[permanent dead link]

Chlorpromazine[edit]

The wholesale cost in the developing world is between US$0.02 and US$0.12 per day.[1] In the United States the wholesale costs is about US$7.80 per day as of 2019.[2]

  1. ^ "Chlorpromazine HCL". International Drug Price Indicator Guide. Retrieved 1 December 2015.
  2. ^ "NADAC as of 2019-02-13". Centers for Medicare and Medicaid Services. Retrieved 14 February 2019.

Chlortalidone[edit]

In the United States the wholesale cost is about US$13.50 a month.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Cholecalciferol[edit]

Cost[edit]

In 2015, the wholesale cost in Costa Rica is about US$2.15 per 30 ml bottle of 10,000 IU/ml.[1] In the United States, human treatment costs less than US$25 per month.[2] In the UK, the cost to the NHS in 2018 for one month's treatment can be less than 3 GBP.[3]

  1. ^ "Single Drug Information | International Medical Products Price Guide". mshpriceguide.org. Retrieved 6 July 2017.
  2. ^ TarasconPP2015, page 231
  3. ^ NICE. "Colecalciferol". Retrieved 3 May 2018.

Ciclosporin[edit]

In 2016, the wholesale cost in the developing world was about US$106 a month.[1] In the United Kingdom, it cost the NHS about £121 per month.[2] The wholesale price in the United States was about US$173 per month.[3]

  1. ^ "Ciclosporin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 632
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 20 December 2016.

Cilostazol[edit]

A month supply in the United Kingdom costs the NHS about 5 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$6.20.[2]

  1. ^ BNF76, pages 231–232
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ciprofloxacin[edit]

It is available as a generic medication and is not very expensive.[1][2] The wholesale cost in the developing world is between US$0.03 and US$0.13 a dose.[3] In the United States it is sold for about US$0.40 per dose.[1]

Cost[edit]

It is available as a generic medication and not very expensive.[1][4] Wholesale it costs between US$0.03 and US$0.13 a dose.[3] In the United States it is sold for about US$0.40 per dose.[1]

  1. ^ a b c d "Ciprofloxacin Hydrochloride". The American Society of Health-System Pharmacists. Archived from the original on 23 September 2015. Retrieved 23 August 2015.
  2. ^ TarasconPP2014, page 85
  3. ^ a b "Ciprofloxacin". International Drug Price Indicator Guide. Retrieved 24 August 2015.
  4. ^ TarasconPP2014, page 85

Cisplatin[edit]

The wholesale cost in the developing world is about US$5.56 to US$7.98 per 50 mg vial.[1] In the United Kingdom this costs the NHS about £17.[2]

  1. ^ "Cisplatin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 605

Clarithromycin[edit]

The wholesale cost in the developing world is between US$0.13 and $0.79 per dose.[1] In the United States it is moderately expensive at $50–100 for a course of treatment.[2]

Cost[edit]

The wholesale cost is between US$0.13 and $0.79 per dose.[3] In the United States it is moderately expensive at $50–100 for a course of treatment.[4]

  1. ^ "Clarithromycin". International Drug Price Indicator Guide. Retrieved 7 September 2015.
  2. ^ TarasconPP2015, page 92
  3. ^ "Clarithromycin". International Drug Price Indicator Guide. Retrieved 7 September 2015.
  4. ^ TarasconPP2015, page 92

Clindamycin[edit]

It is available as a generic medication and is not very expensive.[1] The wholesale cost in the developing world is about US$0.06–0.12 per pill.[2] In the United States, it costs about $2.70 per dose.[3]

Cost[edit]

It is available as a generic medication and is not very expensive.[4] The wholesale cost in the developing world is about US$0.06 to US$0.12 per pill.[5] In the United States it costs about $2.70 per dose.[3]

  1. ^ TarasconPP2015 page 108
  2. ^ "Clindamycin". International Drug Price Indicator Guide. Retrieved 6 September 2015.
  3. ^ a b "Clindamycin Hydrochloride". The American Society of Health-System Pharmacists. Retrieved Sep 4, 2015.
  4. ^ TarasconPP2015, page 108
  5. ^ "Clindamycin". International Drug Price Indicator Guide. Retrieved 6 September 2015.

Clobetasol propionate[edit]

A month supply in the United Kingdom costs the NHS about 7.90 £ as of 2019.[1] In the United States the wholesale cost of this amount is about 66 USD.[2]

  1. ^ BNF76, page 1210
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Clofazimine[edit]

The wholesale cost in the developing world is about US$24 per month.[1]

  1. ^ "Clofazimine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Clomifene[edit]

The wholesale cost in the developing world is about 0.79 to 2.00 USD for a course of treatment.[1] In the United States the wholesale cost of a course of treatment is 4.80 USD.[2]

  1. ^ "Clomifene". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-21 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 26 December 2016.

Clomipramine[edit]

The wholesale price in the developing world is between 0.11 and 0.21 per day as of 2014.[1] In the United States the wholesale costs as of 2018 is about US$9 per day.[2]

  1. ^ "Clomipramine". International Drug Price Indicator Guide. Retrieved 3 December 2015.
  2. ^ "NADAC as of 2018-02-07". Centers for Medicare and Medicaid Services. Retrieved 9 February 2018.

Clonazepam[edit]

The wholesale cost in the developing world is between US$0.01 and US$0.07 per pill.[1] In the United States, the pills are about US$0.40 each.[2]

  1. ^ "Clonazepam". International Drug Price Indicator Guide. Retrieved 15 August 2015.
  2. ^ "Clonazepam". The American Society of Health-System Pharmacists. Retrieved August 15, 2015.

Clonidine[edit]

As of 2019 a month of medication costs the NHS about £8.[1] In the United States this amount costs about US$2.70 as of 2019.[2]

  1. ^ BNF76, page 144
  2. ^ "NADAC as of 2019-01-30". Centers for Medicare and Medicaid Services. Retrieved 3 February 2019.

Clopidogrel[edit]

The wholesale cost in the developing world is about US$0.77–31.59 per month.[1] In the United States, a month of treatment costs less than US$25.[2]

  1. ^ "Clopidogrel Bisulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015 page 147

Clotrimazole[edit]

The wholesale cost in the developing world as of 2014 is 0.20–0.86 USD per 20 gram tube of cream.[1] In the United States a course of treatment typically costs less than US$25.[2]

Society and culture[edit]

The wholesale cost in the developing world as of 2014 is 0.20–0.86 USD per 20gm tube of cream.[1] In the United States treatment typically costs less than US$25.[3]

  1. ^ a b "Clotrimazole". International Drug Price Indicator Guide. Retrieved 28 October 2016.
  2. ^ TarasconP2016, page 176
  3. ^ TarasconPP2015, page 176

Cloxacillin[edit]

The wholesale cost in the developing world is about US$0.16 per day for the pills.[1]

  1. ^ "Cloxacillin Sodium". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Clozapine[edit]

The wholesale cost in the developing world is between US$0.05 and US$2.10 per day as of 2014.[1]

Cost[edit]

The wholesale cost in the developing world is between 0.05 and US$2.10 per day as of 2014.[1] In the United Kingdom the injectable form is about 100 pounds per dose.[2]

  1. ^ a b "Clozapine". International Drug Price Indicator Guide. Retrieved 2 December 2015.
  2. ^ Hewitt J, Haste J (April 2017). "Protocol for the use of intramuscular (IM) clozapine injection" (PDF). Sussex Partnership NHS Foundation Trust. Retrieved 2019-03-15.

Codeine[edit]

The wholesale cost in the developing world is between US$0.04 and US$0.29 per dose as of 2014.[1] In the United States it costs about one dollar a dose.[2]

  1. ^ "Codeine". International Drug Price Indicator Guide. Retrieved 10 January 2016.
  2. ^ "Codeine". The American Society of Health-System Pharmacists. Retrieved 5 January 2016.

Colchicine[edit]

It is available as a generic medication in the United Kingdom where a month's supply costs the NHS about £7.27, as of 2019.[1] In the United States, the wholesale cost of this amount is about US$252.20.[2]

History[edit]

URL Pharma raised the price from $0.09 per tablet to $4.85[3]

  1. ^ BNF76, pages 1085–1086
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "Questions and Answers for Patients and Healthcare Providers Regarding Single-ingredient Oral Colchicine Products". fda.gov.

Colistin[edit]

In the United Kingdom it costs the NHS about £5.40 per day for the injectable form as of 2018.[1] In the United States this amount costs about US$47 as of 2019.[2]

  1. ^ BNF76, page 547
  2. ^ "Colistimethate Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 11 November 2019.

Condom[edit]

The wholesale cost in the developing world is about 0.03 to US$0.08 each.[1] In the United States condoms usually cost less than US$1.00.[2]

  1. ^ "Condoms (Lubricated)". International Medical Products Price Guide. Management Sciences For Health, Inc. Retrieved 2 August 2017.
  2. ^ Shoupe, Donna (2011). Contraception. John Wiley & Sons. p. 15. ISBN 9781444342635.

Copper IUDs[edit]

The wholesale cost in the developing world is about US$0.37–3.00 per IUD.[1] In the United Kingdom they cost the NHS about £10 GBP.[2] In the United States they cost around $750.[3]

  1. ^ "Iud (Copper)". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 557–559
  3. ^ Zieman, Mimi (2012). Managing Contraception 2012–2014. Managing Contraception. p. Chapter 27. ISBN 978-1-4675-3640-0.

Cyanocobalamin[edit]

In the United Kingdom it costs the NHS about 2.90 £ per injection as of 2019.[1] In the United States the wholesale cost of this amount was about US$0.77 in 2019.[2]

  1. ^ BNF76, pages 993–994
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Cyclobenzaprine[edit]

n the United States, the wholesale cost per dose is less than US$0.05 as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Cyclophosphamide[edit]

The wholesale cost in the developing world is about US$3.65–14.30 per 1 g vial.[1] In the United Kingdom this dose costs the NHS about 17.06 pounds.[2] In the United States this dose by mouth is about $19.56.[3]

  1. ^ "Cyclophosphamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 580
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 20 December 2016.

Cycloserine[edit]

The wholesale cost in the developing world is about US$29.70–51.30 per month.[1] In 2015, the cost in the United States was increased to US$3,150 a month and then decreased to US$1,050 per month.[2]

Economics[edit]

In the U.S., the price of cycloserine increased from $500 for 30 pills to $10,800 in 2015 after the Chao Center for Industrial Pharmacy and Contract Manufacturing changed ownership to Rodelis Therapeutics in August 2015.[3] The price increase was rescinded after the previous owner, the Purdue University Research Foundation, which retained "oversight of the manufacturing operation" intervened and Rodelis returned the drug to an NGO of Purdue University. The foundation now will charge $1,050 for 30 capsules, twice what it charged before".[2]

  1. ^ "Cycloserine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ a b Andrew Pollack (21 September 2015). "Big Price Increase for Tuberculosis Drug Is Rescinded". NYT. Retrieved 24 September 2015.
  3. ^ ANDREW POLLACK (20 September 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". Retrieved 21 September 2015.

Cytarabine[edit]

The wholesale cost in the developing world is about US$4.27 to US$5.70 per 500 mg vial.[1] This dose in the United Kingdom costs the NHS about £50.00 while the liposomal form is £1,223.75 per 50 mg vial.[2]

  1. ^ "Cytarabine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 589

Dabigatran[edit]

A month supply in the United Kingdom costs the NHS about £51 as of 2019.Cite error: A <ref> tag is missing the closing </ref> (see the help page).

History[edit]

According to a BBC article in 2008, Dabigatran was expected to cost the NHS £4.20 per day, which was similar to several other anticoagulants.[1]

  1. ^ "Clot drug 'could save thousands'". BBC News Online. 2008-04-20. Retrieved 2008-04-21.

Dacarbazine[edit]

The wholesale cost in the developing world is about US$7.45–18.24 per 200 mg vial.[1] In the United Kingdom this dose costs the NHS about 7.50 pounds.[2]

  1. ^ "Dacarbazine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 600

Dactinomycin[edit]

The wholesale cost in the developing world is about US$24.73 per 500 mcg vial.[1]

  1. ^ "Dactinomycin". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Darunavir[edit]

The wholesale cost in the developing world is about US$66 per month.[1] In the United States it costs more than $200 per month.[2]

  1. ^ "Darunavir". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ TarasconPP2015, page 69

Daunorubicin[edit]

The wholesale cost in the developing world is about 5.79 to 37.18 USD for a 20 mg vial.[1] This amount in the United Kingdom costs the NHS about 55.00 pounds.[2]

  1. ^ "Daunorubicin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 581–583

Deferoxamine[edit]

The wholesale cost in the developing world is about US$6.76 to $13.52 per dose.[1] In the United States a course of treatment costs more than $200.[2]

  1. ^ "Deferoxamine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2014, page 470

Desiccated thyroid extract[edit]

In the United States the wholesale cost for a month of medication is about US$15.30.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Desonide[edit]

Cost[edit]

Desonide topical cream and ointment is sold in 15g and 60g tubes of %0.05 gel, and desonide lotion is sold in 2 fluid ounce bottles.[1] A single 60g tube or one (1) bottle of lotion costs as much as $200.

  1. ^ Drugs.com: Topical Desonide

Desvenlafaxine[edit]

In the United States the wholesale cost is about 25.20 USD per month.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Dexlansoprazole[edit]

In the United States the wholesale cost for a month is about US$270.[1] In Canada this amount costs about 71.50 CAD in 2016 making it the most expensive PPI available at the time.[2]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  2. ^ "[99] Comparative effectiveness of proton pump inhibitors | Therapeutics Initiative". 28 June 2016. Retrieved 14 July 2016.

Dexmethylphenidate[edit]

The wholesale cost of a month supply in the United States is about US$8.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Dextran 70[edit]

The wholesale cost in the developing world is about US$4.10–5.25 per 500 ml.[1] In the United Kingdom this dose costs the NHS about 57.00 pounds.[2] In the United States it costs about $25–50 per dose.[3]

  1. ^ "Dextran 70 6% in Sod. chloride 0.9%". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 686
  3. ^ TarasconPP2015, page 167

Diatrizoate[edit]

As of 2016, the wholesale cost in the developing world is about US$5.49 per 20 ml vial.[1] In the United States a dose costs less than US$25.[2]

  1. ^ "Amidotrizoate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 171

Diazepam[edit]

The wholesale cost in the developing world is about US$0.01 per dose as of 2014.[1] In the United States, it is about US$0.40 per dose.[2]

  1. ^ "Diazepam". International Drug Price Indicator Guide. Retrieved 2 December 2015.
  2. ^ "Diazepam". The American Society of Health-System Pharmacists. Retrieved 2015-06-05.

Diazoxide[edit]

In the United States as of 2019 it costs about US$1500 per month.[1] In the United Kingdom this amount costs the NHS about £59.[2]

  1. ^ "Proglycem Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 11 October 2019. Typical dose is 3mg/kg * 70 kg * 30 days = 6,300 mg at 11.58 per 50 mg
  2. ^ BNF76, page 708

Diclofenac[edit]

The wholesale cost in the developing world is generally less than US$2 per month as of 2015.[1] In the United States the wholesale cost of this amount is typically less than US$9 as of 2018.[2]

Cost[edit]

In the United States the NADAC per dose is less than US$0.15 as of 2018 for 50 mg and 75 mg tablets.[3] The average wholesale cost in the United States in 2019 is about US$50 to $US100 per month at a typical dose.[4]

  1. ^ "Diclofenac Sodium". International Medical Products Price Guide. Retrieved 4 December 2019.
  2. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  3. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  4. ^ TarasonPP2019, page 6

Dicycloverine[edit]

In the United Kingdom the NHS pays about 1.84 £ per dose as of 2019.[1] In the United States the wholesale cost of this amount is about 0.15 USD.[2]

  1. ^ BNF76, page 759
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Diethylcarbamazine[edit]

The wholesale cost in the developing world is around one US penny per dose.[1]

  1. ^ "Diethylcarbamazine Citrate". International Drug Price Indicator Guide. Retrieved 1 December 2016.

Digoxin[edit]

The wholesale cost in the developing world is about US$0.21 to $6.60 a month.[1] In the United States it generally costs less than $25 per month, as of 2015.[2]

  1. ^ "Digoxin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015

Diltiazem[edit]

In the United States the wholesale cost per day of the by mouth formulation is less than 0.70 USD as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Diphenhydramine[edit]

The wholesale price in the developing world as of 2014 is about US$0.01 per dose.[1] In the United States, it costs less than US$25 for a typical month’s supply.[2]

  1. ^ "Diphenhydramine". International Drug Price Indicator Guide. Retrieved 28 September 2016.
  2. ^ TarasconPP2015, page 240

Diphtheria vaccine[edit]

The wholesale price in the developing world of a version that contains tetanus toxoid is between 0.12 and 0.99 USD per dose as of 2014.[1] In the United States it is less than 25 USD.[2]

  1. ^ "Vaccine, Diphtheria-Tetanus". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 313

Docetaxel[edit]

The wholesale cost in the developing world is about US$15.53 to US$87.37 per 80 mg vial.[1] This dose in the United Kingdom costs the NHS about £454.53.[2]

Costs[edit]

In the UK (in 2009) The cost of six cycles (18 weeks) of docetaxel at a dose of 75 mg/m2 IV every 21 days is £5,262 (based on an average body surface area 1.75 m2).[3]

  1. ^ "Docetaxel". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 622
  3. ^ http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2009/jan-apr/Cabazitaxel.pdf ref : National Institute for Health and Clinical Excellence. Prostate cancer (hormone-refractory) — docetaxel: analysis of cost impact London: NICE; September 2006. "Archived copy". Retrieved 2010-06-10.

Docosanol[edit]

When introduced in Canada in 2005 it sold for CA$6.12 per gram of 10% cream.[1] In the United States in 2019 this amount cost US$10.36.[2]

  1. ^ "Report on New Patented Drugs - Abreva". pmprb-cepmb.gc.ca. 13 May 2014. Retrieved 25 November 2019.
  2. ^ "Docosanol topical Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 25 November 2019.

Donepezil[edit]

In the United Kingdom a typical months supply costs the NHS about £8.44 as of 2019.[1] The wholesale cost of this amount in the United States is about US$1.38. [2]

  1. ^ BNF76, page 300
  2. ^ "NADAC as of 2019-01-30". Centers for Medicare and Medicaid Services. Retrieved 4 February 2019.

Dopamine (medication)[edit]

The wholesale cost in the developing world of a container of 400 mg is between $0.28 and $0.60 (USD) as of 2014.[1]

  1. ^ "Dopamine". International Drug Price Indicator Guide. Retrieved 5 December 2015.

Dorzolamide[edit]

A 5 milliliter bottle in the United Kingdom costs the NHS less than 2 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$7.10.[2]

  1. ^ BNF76, page 1148
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Dorzolamide/timolol[edit]

A 5 milliliter bottle in the United Kingdom costs the NHS about 1.50 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$8.30.[2]

Cost[edit]

The brand name Cosopt currently costs upwards of $200 after discounts[3] while the generic formulation costs around $70 cash.[4] The more recent preservative free formulation can be purchased for less than the original brand name formulation at around $160[5]

  1. ^ BNF 76, page 1149
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "Prices and Coupons for Cosopt". Retrieved 2017-10-29.
  4. ^ "Prices and Coupons for Cosopt". www.goodrx.com. Retrieved 2017-10-29.
  5. ^ "Prices and Coupons for Cosopt PF". www.goodrx.com. Retrieved 2017-10-29.

Doxazosin[edit]

A month supply in the United Kingdom costs the NHS about 0.50 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$5.50.[2]

  1. ^ BNF 76, page 765
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Doxepin[edit]

A month supply in the United Kingdom costs the NHS at least 100 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$23.[2]

  1. ^ BNF 76, page 372
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Doxorubicin[edit]

The wholesale cost in the developing world is about US$3.88–32.79 per 50 mg vial.[1] In the United Kingdom this amount costs the NHS about £100.12.[2][3]

  1. ^ "Doxorubicin HCL". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Doxorubicin British National Formulary". BNF. Retrieved 6 March 2017.
  3. ^ BNF69, page 583

Doxycycline[edit]

The wholesale cost in the developing world is between US$0.01 and US$0.04 per pill.[1] In the United States, ten days of treatment has a wholesale costs of about US$3.40 as of 2019.[2] However, in 2014, due to supply issues, it was being sold for as much as US$60.00–200.00 for that amount.[3][4]

History[edit]

The market price for doxycycline dramatically increased in the United States in 2013 and early 2014 (from $20 to over $1800 for a bottle of 500 tablets),[5][6][7] before decreasing again.[8][9]

Society and culture[edit]

Doxycycline is available as a generic medicine and is generally inexpensive.[3][10] The wholesale cost is between US$0.01 and $0.04 per pill.[1]

  1. ^ a b "Doxycycline". International Medical Products Price Guide. Retrieved 16 January 2018.
  2. ^ "NADAC as of 2019-09-11 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 10 September 2019.
  3. ^ a b "Doxycycline calcium". The American Society of Health-System Pharmacists. Retrieved 18 August 2015.
  4. ^ "Officials Question the Rising Costs of Generic Drugs". New York Times. 7 October 2014. Retrieved 22 September 2015.
  5. ^ Sudden increase in cost of common drug concerns many Archived 31 December 2014 at the Wayback Machine, WSMV-TV, 12 March 2013 (updated 26 March 2013).
  6. ^ Rosenthal, Elisabeth, Officials Question the Rising Costs of Generic Drugs Archived 23 February 2017 at the Wayback Machine, The New York Times, 7 October 2014.
  7. ^ Eric Palmer for FiercePharmaManufacturing. 13 March 2014 Hikma hits the jackpot with doxycycline shortage Archived 1 January 2015 at the Wayback Machine
  8. ^ "Costco Drug Information". Retrieved 31 July 2016.
  9. ^ "Doxycycline Hyclate Prices and Doxycycline Hyclate Coupons". GoodRx. Retrieved 31 July 2016.
  10. ^ TarasconPP2011, page 79

Duloxetine[edit]

In the United States the wholesale cost per dose is about US$0.20 as of 2018.[1] In 2016 it was the 48th most prescribed medication in the United States with more than 15 million prescriptions.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Dutasteride[edit]

A month supply in the United Kingdom costs the NHS about £12 as of 2019.[1] In the United States, the wholesale cost of this amount is about $6.66.[2]

  1. ^ BNF76, page 769
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Efavirenz[edit]

The wholesale cost in the developing world is about US$3.27 to 9.15 per month.[1] As of 2015 the cost for a typical month of medication in the United States is more than US$200.[2]

Society and culture[edit]

A one-month supply of 600 mg tablets costs approximately US$1,010 in July 2016.[3] In 2007, Merck provided Efavirenz in certain developing countries and countries largely affected by HIV for about US$0.65 per day.[4] Some emerging countries have opted to purchase Indian generics.[5] In Thailand, a one month supply of efavirenz + Truvada, as of June 2012, cost 2,900 baht (US$90), and there is a social program for patients who cannot afford the medication. As of 2018 Thailand will produce efavirenz domestically. Its Government Pharmaceutical Organization product costs 180 baht per bottle of thirty 600 mg tablets. The imported version in Thailand retails for more than 1,000 baht per bottle. GPO will devote 2.5 percent of its manufacturing capacity to make 42 million efavirenz pills in 2018, allowing it to serve export markets as well as domestic. The Philippines alone will order about 300,000 bottles of efavirenz for 51 million baht.[6]

  1. ^ "Efavirenz". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ TarasconPP2015, page 62
  3. ^ "Cost Considerations and Antiretroviral Therapy | Adult and Adolescent ARV Guidelines | AIDSinfo". AIDSinfo. Retrieved 2016-11-16.
  4. ^ "Merck & Co., Inc., Again Reduces Price of Stocrin (Efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic". Drugs.com MedNews.
  5. ^ IndiaDaily - A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck's patent on AIDS drug Efavirenz Archived 2008-02-19 at the Wayback Machine
  6. ^ Wipatayotin, Apinya (3 November 2018). "Thailand gets nod to make HIV/Aids drug". Bangkok Post. Retrieved 3 November 2018.

Efavirenz/emtricitabine/tenofovir[edit]

The wholesale cost in the developing world is about US$10.71–14.19 per month as of 2014.[1] The wholesale cost in the United States is about $2308.20 a month as of 2016, while in the United Kingdom it costs the NHS £532.87 per month as of 2015.[2][3]

History[edit]

An equivalent two pill regimen is available in developing countries at a price of about US$1.00 per day, as Gilead Sciences has licensed the patents covering emtricitabine/tenofovir to the Medicines Patent Pool[4] and Merck and Co makes efavirenz available in developing countries at a reduced price.[5]

Cost[edit]

The wholesale cost in the developing world is about US$10.71–14.19 per month as of 2014.[1]

  1. ^ a b "Efavirenz + Emtricitabine + Tenofovir Df". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 12 December 2016.
  3. ^ BNF69, page 423
  4. ^ "Medicines Patent Pool Signs Licence Agreement with Gilead to Increase Access to HIV/AIDS Medicines".
  5. ^ "HIV & AIDS Information :: Merck cuts price of efavirenz for developing countries again".

Empagliflozin[edit]

A month supply in the United Kingdom costs the NHS about £36.59 as of 2019.[1] In the United States the wholesale cost of this amount is about US$442.[2]

  1. ^ BNF76, page 691
  2. ^ "NADAC". Centers for Medicare and Medicaid Services. 27 February 2019. Retrieved 3 March 2019.

Emtricitabine/tenofovir[edit]

The 2015 wholesale cost in the developing world is about US$6.06 to US$7.44 per month.[1] In the United States, as of 2019, the wholesale cost is about US$1,710.00 per month.[2] In Australia, this amount costs about US$8.[3]

Cost[edit]

As of 2014, the median cost per tablet, in Namibia and South Africa, was US$0.20.[1] In Canada, emtricitabine/tenofovir cost between $800 - $1,100 per month in 2016.[4] Generic emtricitabine/tenofovir was approved by Health Canada in August 2017, with a wholesale cost of $400 per month.[5] The cost for emtricitabine/tenofovir PrEP in Ontario, Canada dropped significantly after approval in September 2017.[6] In the United States, as of 2016, the wholesale cost is about US$1,415.00 per month.[7] This increased in 2019 to about US$1,710.00 per month.[2] The price of emtricitabine/tenofovir in the United States has been criticized by activists, who argued in a 2018 The New York Times opinion piece that the high cost keeps the drug out of reach for millions, thus harming efforts to reduce new HIV infections.[8] The Gilead CEO defended the high price at a U.S. House of Representatives committee hearing.[9] Generic emtricitabine/tenofovir was approved in the United States in 2018,[10] and it is scheduled to be released by Teva in September 2020.[11]

  1. ^ a b "Tenofovir DF+Emtricitabine". International Drug Price Indicator Guide. Management Sciences for Health and World Health Organization. 2014. Retrieved 2015-08-01.
  2. ^ a b "NADAC as of 2019-11-13 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 15 November 2019.
  3. ^ "AOC asks pharma CEO why $2,000 HIV drug costs just $8 in Australia". The Independent. 17 May 2019. Retrieved 15 November 2019.
  4. ^ "Pre-Exposure Prophylaxis (PrEP) as a form of HIV prevention". AIDS Committee of Toronto. Retrieved 2016-11-01.
  5. ^ "Generic tenofovir + FTC coming to Canada". www.catie.ca. Retrieved 30 August 2017.
  6. ^ "PrEP in Ontario" (PDF). AIDS Committee of Toronto. 28 September 2017. Retrieved 31 October 2019.
  7. ^ "NADAC as of 2016-12-07". Centers for Medicare and Medicaid Services (CMS). Retrieved 12 December 2016.
  8. ^ Krellenstein J, Lord A, Staley P (16 July 2018). "Why Don't More Americans Use PrEP?". The New York Times. Retrieved 30 July 2018.
  9. ^ Grover N (17 May 2019). "Under fire for Truvada US pricing at House hearing, Gilead chief O'Day touts R&D costs, asserts governments patents are void". Endpoints News. Retrieved 31 October 2019.
  10. ^ "2018 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 2019-11-01. Retrieved 29 October 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  11. ^ "Gilead Sciences Form 10-Q Quarterly Filing". Gilead Sciences. 31 March 2019. Retrieved 29 October 2019.

Enalapril[edit]

The wholesale cost in the developing world is about US$0.08 to 0.80 per month.[1] In the United States, it costs about $25 to $50 per month.[2]

  1. ^ "Enalapril". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 120

Enoxaparin sodium[edit]

The wholesale cost in the developing world is about US$1.90–10.80 per day.[1] In the United States the wholesale cost is about $14.13 per day as of 2016.[2]

  1. ^ "Enoxaparin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 15 December 2016.

Ephedrine[edit]

The wholesale cost in the developing world is about US$0.69–1.35 per dose.[1] In the United States it is not very expensive.[2]

  1. ^ "Ephedrine". International drug price indicator guide. Retrieved 1 January 2016.
  2. ^ TarasconPP2015, page 162

Epinephrine (medication)[edit]

The wholesale cost in the developing world is between US$0.10 and US$0.95 a vial.[1] In the United States, the cost of the most commonly used autoinjector for anaphylaxis was about US$600 for two in 2016, while a generic version was about US$140 for two.[2] In Canada the wholesale cost of two cost is CA$190 as of 2019.[3]

Cost[edit]

The wholesale cost of epinephrine in the developing world is between US$0.10 and US$0.95 a vial.[1] In the United States, the cost of the most commonly used autoinjector for anaphylaxis was about US$600 for two in 2016, while a generic version was about US$140 for two.[2] In Canada the wholesale cost of two cost is CA$190 as of 2019.[3]

  1. ^ a b "Epinephrine". International Drug Price Indicator Guide. Retrieved 15 August 2015.
  2. ^ a b Ginger Skinner (August 11, 2016). "Can You Get A Cheaper EpiPen?". Consumer Reports.
  3. ^ a b "[119] Epinephrine autoinjectors available in Canada". Therapeutics Initiative. 23 May 2019. Retrieved 26 May 2019.

Ergometrine[edit]

The wholesale cost in the developing world is between US$0.12 and US$0.41 for an injectable dose and US$0.01 for a pill as of 2014.[1][2] In the United States it is about US$1.75 per dose.[3]

  1. ^ "Ergometrine Maleate". International Drug Price Indicator Guide. Retrieved 25 December 2015.
  2. ^ "Ergometrine Maleate". International Drug Price Indicator Guide. Retrieved 25 December 2015.
  3. ^ "Ergonovine Maleate". The American Society of Health-System Pharmacists. Retrieved 1 December 2015.

Erlotinib[edit]

In the United States, as of 2019, it costs about US$8,832 per month.[1] In the United Kingdom this amount costs the NHS about £1,631.53 per month.[2]

Price[edit]

In the United States, as of 2019, it costs about US$8,832 per month.[1] In the United Kingdom this amount costs the NHS about £1,631.53 per month.[2]

  1. ^ a b "Tarceva Prices, Coupons & Patient Assistance Programs". Drugs.com.
  2. ^ a b BNF76, page 950

Erythromycin[edit]

It is available as a generic medication and is not very expensive.[1] The wholesale price in the developing world is between 0.03 and 0.06 USD per tablet.[2]

Cost[edit]

It is available as a generic medication and was inexpensive for many years.[1] The wholesale price was between 0.03 and 0.06 USD per pill.[2] In the United States in 2014 the price increased to seven dollars per tablet.[3] The price of Erythromycin rose three times between 2010 and 2015, from 24 cents per tablet in 2010 to $8.96 in 2015.[4] In 2017, a Kaiser Health News study found that the per-unit cost of dozens of generics doubled or even tripled from 2015 to 2016, increasing spending by the Medicaid program. Due to price increases by drug manufacturers, Medicaid paid on average $2,685,330 more for Erythromycin in 2016 compared to 2015 (not including rebates).[5] By 2018, generic drug prices had climbed another 5% on average.[6]

  1. ^ a b TarasconPP2013, page 72
  2. ^ a b "Erythromycin". International Drug Price Indicator Guide. Retrieved 23 August 2015.
  3. ^ Stahl, Stephanie (September 26, 2014) Health: Generic Drugs Prices Increasing Archived 2016-04-09 at the Wayback Machine CBS Philadelphia. Retrieved March 24, 2016.
  4. ^ "Some Generic Drugs See Huge Price Increases". www.medscape.com. Retrieved 29 June 2018.
  5. ^ "Climbing cost of decades-old drugs threatens to break Medicaid bank". Philly.com. Retrieved 29 June 2018.
  6. ^ "Are Drugs Really Getting More Expensive? Yes". The GoodRx Prescription Savings Blog. 27 February 2018. Retrieved 29 June 2018.

Erythropoiesis-stimulating agent[edit]

The wholesale cost of one version in the developing world, as of 2015, is about 3.80 USD per 2000 unit vial.[1] In the United Kingdom this amount costs about 10 pounds as of 2015.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 10 December 2017.
  2. ^ BNF69, pages 666–671

Escitalopram[edit]

In the United States the wholesale cost is about $2.04 per month as of 2017.[1] In the United Kingdom, as of 2018, non-proprietary escitalopram is around 1 / 20th as costly as the proprietary version.[2]

  1. ^ "NADAC as of 2017-12-27". Centers for Medicare and Medicaid Services. Retrieved 31 December 2017.
  2. ^ "Escitalopram Medicinal Forms". BNF. 2018. Retrieved 27 September 2018. Link restricted to the UK.

Esomeprazole[edit]

A month supply in the United Kingdom costs the NHS about £3 as of 2019.[1] In the United States the wholesale cost of this amount is about 10 USD.[2]

  1. ^ BNF76, page 78
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Eszopiclone[edit]

In the United States the wholesale cost is about 0.20 USD per dose.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ethambutol[edit]

The wholesale cost in the developing world is about US$2.58–4.73 per month.[1] In the United States it costs US$100–200 per month.[2]

  1. ^ "Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 48

Ethambutol/isoniazid[edit]

The wholesale cost in the developing world is about 1.47 to 1.99 USD a month.[1]

  1. ^ "Ethambutol + Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Ethambutol/isoniazid/rifampicin[edit]

The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.[1]

  1. ^ "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Ethinylestradiol/etonogestrel[edit]

In the United States the wholesale cost of this amount is about US$468.78.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ethionamide[edit]

The wholesale cost in the developing world is about $5.94 to $24.12 USD per month.[1]

  1. ^ "Ethionamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Ethosuximide[edit]

The wholesale cost in the developing world is about US$27.77 per month as of 2014.[1] In the United States the wholesale cost of this amount is about US$95.97 per month.[2]

  1. ^ "Ethosuximide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2019-11-27 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 3 December 2019.

Etonogestrel birth control implant[edit]

The wholesale cost in the developing world is about 8.93 to 13.29 USD.[1] In the United Kingdom the device costs the NHS about 83.43 pounds.[2] The cost in the United States is about 625.00 USD.[3]

  1. ^ "Etonogestrel". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF76, page 791
  3. ^ Wipf J (2015). Women's Health, An Issue of Medical Clinics of North America. Elsevier Health Sciences. pp. 507–509. ISBN 9780323376082. Archived from the original on 2017-09-24.

Etoposide[edit]

The wholesale cost in the developing world is about US$3.24 to US$5.18 per 100 mg vial.[1] In the United Kingdom this costs the NHS about £12.15 as of 2015.[2]

  1. ^ "Etoposide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 593

Exenatide[edit]

A month supply in the United Kingdom costs the NHS about £82 for the daily injectable and £73 for the weekly injectable version as of 2019.[1] In the United States the wholesale cost of this amount is about US$700 and US$789 respectively.[2] In 2016 it was the 293rd most prescribed medication in the United States with more than a million prescriptions.[3]

  1. ^ BNF76, pages 684–685
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Ezetimibe[edit]

A month supply in the United Kingdom costs the NHS about £26.21 as of 2019.[1] In the United States the wholesale cost of this amount is about US$5.85.[2]

Cost[edit]

In the United States as of 2019 it costs about 0.21 USD per dose.[2] In 2015, it cost between US$4.84 and 7.88.[3]

  1. ^ BNF76, page 196
  2. ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Langreth, Robert (June 29, 2016). "Decoding Big Pharma's Secret Drug Pricing Practices". Bloomberg. Retrieved 15 July 2016.

Factor VIII (medication)[edit]

The wholesale cost in the developing world is about US$119–497 per 500 IU vial.[1]

  1. ^ "Factor Viii". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Famotidine[edit]

A month supply in the United Kingdom costs the NHS about 30 ₤ as of 2019.[1] In the United States the wholesale cost of this amount is about 2 USD.[2]

  1. ^ BNF76, pages 74–75
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Febuxostat[edit]

In the United Kingdom a month of treatment costs the NHS about 24 pounds.[1] In the United States the wholesale cost of a month's worth of medication is about US$320.[2]

  1. ^ BNF76, page 1087
  2. ^ "NADAC as of 2019-02-20". Centers for Medicare and Medicaid Services. Retrieved 26 February 2019.

Fenofibrate[edit]

A month supply in the United Kingdom costs the NHS about 3.67 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$8.40.[2]

  1. ^ BNF76, page 198
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Fentanyl[edit]

For a 100 microgram vial, the average wholesale cost in the developing world was US$0.66 in 2015.[1] In 2017, the price in the United States was US$0.49 for that same amount.[2]

Cost[edit]

The wholesale cost in the developing world as of 2015 is between US$0.08 and US$0.81 per 100 microgram vial.[1] In the United States this amount costs about US$0.40 as of 2017.[2] In the United States the patches cost US$11.22 for a 12 µg/hr version and US$8.74 for a 100 µg/hr version.[2]

  1. ^ a b "Single Drug Information". International Medical Products Price Guide. Retrieved 14 December 2017.
  2. ^ a b c "NADAC as of 2017-12-13". Centers for Medicare and Medicaid Services. Retrieved 14 December 2017.

Ferrous salt/folic acid[edit]

The wholesale cost in the developing world is about 0.07 to 1.02 USD a month.[1] In the United Kingdom, it costs the NHS about 2.64 to 4.25 pounds per month.[2]

  1. ^ "Ferrous Salt + Folic Acid". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 661

Filgrastim[edit]

The wholesale cost in the developing world is about US$3.95 to US$94.66 per dose.[1][2] In the United Kingdom it cost the NHS about £50.15 per 300 μg dose.[3] In the United States treatment costs more than US$200.[4] Filgrastim biosimilar medications are also available.[5]

  1. ^ "Filgrastim". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Filgrastim- ERC: International Drug Price Indicator Guide". erc.msh.org. Retrieved 19 December 2016.
  3. ^ BNF69, page 678
  4. ^ TarasconPP2015, page 292
  5. ^ "Filgrastim". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.

Finasteride[edit]

A month supply in the United Kingdom costs the NHS about £0.89 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.34.[2]

  1. ^ BNF76, page 769
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Flecainide[edit]

A month supply in the United Kingdom costs the NHS about £7.68 as of 2019.[1] In the United States the wholesale cost of this amount is about 18.60 USD.[2]

  1. ^ BNF76, page 103
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Fluconazole[edit]

The wholesale cost in the developing world is about US$0.05–0.10 per day.[1] In the United States the wholesale price is about US$1.14–1.75 per day as of 2016.[2]

  1. ^ "Fluconazole". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 11 December 2016.

Fludarabine[edit]

The wholesale cost in the developing world is about US$54.00 per 50 mg vial.[1] In the United Kingdom it costs about 155.00 pounds per 50 mg vial.[2]

  1. ^ "Fludarabine Phosphate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 590

Fluorescein (medical use)[edit]

The wholesale cost in the developing world is about US$12.25 per 5 ml bottle.[1] In the United Kingdom a single dose costs the NHS about 0.43 pounds.[2] It is also not very expensive in the United States.[3]

  1. ^ "Fluorescein". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 769, 772
  3. ^ TarasconPP2015, page 416

Fluorouracil[edit]

The wholesale cost in the developing world is about US$1.18–3.40 per 500 mg vial.[1] In the United Kingdom this amount costs the NHS about £6.40.[2] In the United States it costs about $18.71.[3]

  1. ^ "Fluorouracil". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 590
  3. ^ "Fluorouracil Prices, Coupons & Patient Assistance Programs - Drugs.com". Drugs.com. Retrieved 27 June 2017.

Fluoxetine[edit]

The wholesale cost in the developing world is between US$0.01 and US$0.04 per day as of 2014.[1] In the United States, it costs about US$0.85 per day.[2] In 2016 it was the 29th most prescribed medication in the United States with more than 23 million prescriptions.[3]

  1. ^ Frye JE, Johnson K, eds. (2014). "Fluoxetine" (PDF). International Drug Price Indicator Guide. Medford, Massachusetts: Management Sciences for Health.
  2. ^ "Fluoxetine Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 2 December 2015.
  3. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Fluphenazine[edit]

In the United States the tablets costs between $0.22 and $0.42 per day for a typical dose.[1] The wholesale cost in the developing world of the long acting form is between US$0.20 and US$6.20 per injection as of 2014.[2]

Availability[edit]

In the United States the tablets costs between 0.22 and 0.42 USD per day for a typical dose.[1] The wholesale cost in the developing world of the long acting form is between 0.20 and 6.20 USD per injection as of 2014.[2]

  1. ^ a b {{cite web|title=fluphenazine decanoate|url=https://www.drugs.com/monograph/fluphenazine-decanoate.html%7Cpublisher=The American Society of Health-System Pharmacists|access-date=Dec 1, 2015}
  2. ^ a b "Fluphenazine Decanoate". International Drug Price Indicator Guide. Retrieved 2 December 2015.

Fluticasone propionate[edit]

In the United States the wholesale cost per spray is about 0.33 USD as of 2018.[1] In the United Kingdom, it costs the NHS about 0.13 GBP per spray as of 2019.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, pages 262, 1172

Fluticasone/salmeterol[edit]

A two month supply in the United Kingdom costs the National Health Service about £35 per month as of 2019.[1] In the United States the wholesale cost of this amount is about 89 USD.[2]

  1. ^ BNF76, pages 263–264
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Folate[edit]

The wholesale cost of supplements in the developing world is between US$0.001 and 0.005 per dose as of 2014.[1]

  1. ^ "Folic Acid". International Drug Price Indicator Guide. Retrieved 1 September 2016.

Fremanezumab[edit]

The wholesale cost in the United States as of 2019 is $US 369.90 per month.[1]

  1. ^ "NADAC as of 2019-07-10 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 15 July 2019.

Furosemide[edit]

In the United States, it is available as a generic medication and costs about US$0.15 per day.[1]

  1. ^ "Furosemide". The American Society of Health-System Pharmacists. Archived from the original on 2015-11-19. Retrieved October 23, 2015.

Gabapentin[edit]

The wholesale price in the developing world as of 2015 was about US$10.80 per month;[1] in the United States, it was US$100 to US$200.[2]

  1. ^ "Gabapentin". International Drug Price Indicator Guide. Retrieved 13 March 2016.
  2. ^ TarasconPP2015, page 327

Gemcitabine[edit]

The wholesale cost in the developing world is about US$24.41 to $316.99 per gram vial.[1] In the United Kingdom a 1 g vial costs the NHS approximately £155.[2]

  1. ^ "Gemcitabine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 590

Gemfibrozil[edit]

A month supply in the United Kingdom costs the NHS about 30 £ as of 2019.[1] In the United States the wholesale cost of this amount is about 6 USD.[2]

  1. ^ BNF76, pages 198–199
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Gentamicin[edit]

The injectable's wholesale cost in the developing world in 2014 was between US$0.05 and US$0.58 per mL.[1]

  1. ^ "Gentamicin sulfate". International Drug Price Indicator Guide. Retrieved 15 August 2015.

Glecaprevir/pibrentasvir[edit]

In the United States, a course of treatment costs about $27,600 as of 2019.[1] This amount in the United Kingdom costs the NHS about £26,000 as of 2018.[2]

Cost[edit]

In the United States, a course of treatment costs about $27,600 as of 2019.[3] This amount in the United Kingdom costs the NHS about £26,000 as of 2018 while in Canada it is CA$40,000.[2][4]

  1. ^ "Mavyret Prices, Coupons & Patient Assistance Programs". Drugs.com.
  2. ^ a b BNF76, page 620
  3. ^ "Mavyret Prices, Coupons & Patient Assistance Programs". Drugs.com.
  4. ^ "Pharmacoeconomic Review Report: Glecaprevir / Pibrentasvir (Maviret): (AbbVie Corporation): Indication: Hepatitis C genotype 1 to 6 [Internet]". February 2018. PMID 30462452. {{cite journal}}: Cite journal requires |journal= (help)

Glibenclamide[edit]

A month supply in the United Kingdom costs the NHS about £3.20 as of 2019.[1] In the United States the wholesale cost of this amount is about $2.50.[2]

  1. ^ BNF76, page 692
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Gliclazide[edit]

The wholesale cost in the developing world is about US$2.46–3.92 per month.[1] In the United Kingdom a month of medication costs the NHS about 2.12 pounds.[2]

  1. ^ "Gliclazide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 474

Glimepiride[edit]

A month supply in the United Kingdom costs the NHS about 7.00 £ per month as of 2019.[1] In the United States, the wholesale cost of this amount is about 2.15 USD.[2]

  1. ^ BNF76, page 693
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Glipizide[edit]

In the United States the wholesale cost per dose is less than 0.05 USD as of 2018.[1] In the United Kingdom it costs the NHS less than 0.05 pounds per dose as of 2018.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 693

Glucagon (medication)[edit]

The wholesale cost in the developing world is about US$25.75 a dose.[1] In the United Kingdom that dose costs the NHS about £11.52.[2] In the United States the wholesale cost of a dose is US$247.32.[3]

  1. ^ "Glucagon". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 487
  3. ^ "NADAC as of 2016-12-21 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 27 December 2016.

Glutaraldehyde[edit]

The wholesale cost in the developing world is about US$1.50–7.40 per liter of 2% solution.[1]

History and culture[edit]

The wholesale cost in the developing world is about US$1.50–7.40 per liter of 2% solution.[2]

  1. ^ "Glutaraldehyde". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Glutaraldehyde". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Griseofulvin[edit]

The wholesale cost in the developing world is about US$0.05–0.18 per day.[1] In the United States a course of treatment costs $100–200.[2]

  1. ^ "Griseofulvin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 44

Guaifenesin[edit]

In the United States the wholesale cost is less than 0.10 USD per dose.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Guanfacine[edit]

A month supply in the United Kingdom costs the NHS about £60 as of 2019.[1] In the United States the wholesale cost of this amount is about 7.11 USD.[2]

  1. ^ BNF76, pages 349–350
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

HPV vaccine[edit]

The wholesale cost in the developing world is about US$47 a dose as of 2014.[1] In the United States, it costs more than US$200.[2]

<<Extensive discussion of cost-effectiveness and costs in countries worldwide>>

  1. ^ "Vaccine, Hpv". International Drug Price Indicator Guide. Retrieved 6 December 2015. {{cite web}}: Cite has empty unknown parameter: |1= (help)
  2. ^ TarasconPP2015, page 314

Halothane[edit]

As of 2014, the wholesale cost in the developing world is about 22 to 52 USD for a 250 mL bottle.[1]

Society and culture[edit]

As of 2014, the wholesale cost in the developing world was 22 to 52 USD for a 250 mL bottle.[2]

  1. ^ "Halothane". International Drug Price Indicator Guide. Retrieved 13 August 2015.
  2. ^ "Halothane". International Drug Price Indicator Guide. Retrieved 13 August 2015.

Hand sanitizer[edit]

The wholesale cost in the developing world is about US$1.40–3.70 per liter bottle.[1][2]

  1. ^ "Alcohol, isopropyl". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ The selection and use of essential medicines: Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children) (PDF). WHO. 2015. p. 323. ISBN 9789240694941. Archived (PDF) from the original on 20 December 2016. Retrieved 8 December 2016.

Heparin[edit]

The wholesale cost in the developing world, when used for prevention, is about US$9.63–37.95 per month.[1] In the United States it costs about $25–50 per month.[2]

  1. ^ "Heparin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015

Hepatitis B vaccine[edit]

As of 2014, the wholesale cost in the developing world is US$0.58–13.20 per dose.[1] In the United States it costs US$50–100.[2] |Costa Rica ||97

  1. ^ "Vaccine, Hepatitis B". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 314

Hib vaccine[edit]

The wholesale cost of a pentavalent vaccine which includes Hib in the developing world was US$15.40 per dose as of 2014.[1] In the United States it costs about $25–50 per dose.[2]

  1. ^ "Vaccine, Pentavalent". International Drug Price Indicator Guide. Retrieved 7 December 2015.
  2. ^ TarasconPP2015, page 313

Hormonal IUDs[edit]

The wholesale cost in the developing world is about US$122.46 each.[1] In the United Kingdom they cost the NHS about £88.[2] In the United States they cost around US$844.00,[3]

  1. ^ "IUD (Levonorgestrel)". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 556
  3. ^ Zieman, Mimi (2012). "Chapter 27". Managing Contraception 2012–2014. Managing Contraception. ISBN 9781467536400.

Hydralazine[edit]

The wholesale cost in the developing world is about US$2.78–9.11 per month.[1] In the United States treatment costs about $50–100 per month.[2]

  1. ^ "Hydralazine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 145

Hydrochlorothiazide/triamterene[edit]

A month supply in the United Kingdom costs the NHS about 0.95 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about 3.90 USD.[2]

  1. ^ BNF76, page 76
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Hydrocodone[edit]

In the United States the wholesale cost of the long-acting formulation is about 10 to 30 USD per dose as of 2019.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Hydrocortisone[edit]

The wholesale cost in the developing world is about US$0.27 per day as of 2014 for the form taken by mouth.[1] In the United States, it costs less than US$25 for a typical month of treatment.[2]

  1. ^ "Hydrocortisone". International Drug Price Indicator Guide. Retrieved 1 September 2016.
  2. ^ TarasconPP2015, page 202

Hydromorphone[edit]

In the United Kingdom it costs the NHS about £0.32 per 2 mg tablet as of 2019.[1] In the United States the wholesale cost of this amount is about US$0.07.[2]

  1. ^ BNF76, pages 24, 456
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Hydroxocobalamin[edit]

The wholesale cost in the developing world is about US$0.12 to US$0.84 per dose (1 ml with 1 mg/ml concentration).[1] In the United States the same amount costs about US$0.84 wholesale.[2]

  1. ^ "Vitamin B12". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 30 December 2016. {{cite web}}: Cite has empty unknown parameter: |1= (help)

Hydroxycarbamide[edit]

The wholesale cost in the developing world is about US$0.35–0.47 per day.[1] In the United States it costs less than $25 a month.[2]

  1. ^ "Hydroxycarbamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 295

Hydroxychloroquine[edit]

The wholesale cost in the developing world is about $5.40 to 7.44 per month.[1] In the United Kingdom this dose costs the NHS about £5.15.[2] In the United States the wholesale cost of a month of treatment is about US$25 as of 2019.[3]

  1. ^ "Hydroxychloroquine Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 730
  3. ^ "NADAC as of 2019-08-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 9 August 2019.

Hydroxyzine[edit]

In the United Kingdom 28 doses cost less than a pound.[1] In the United States the wholesale cost in 2018 was about 0.05 USD per dose.[2]

  1. ^ BNF74
  2. ^ "NADAC as of 2018-11-21". Centers for Medicare and Medicaid Services. Retrieved 21 Nov 2018.

Hyoscine butylbromide[edit]

The wholesale cost in the developing world is US$0.004–0.11 per pill as of 2014.[1]

  1. ^ "Hyoscine Butylbromide". International Drug Price Indicator Guide. Retrieved 4 December 2015.

Ibuprofen[edit]

The wholesale cost in the developing world is between US$0.01 and US$0.04 per dose.[1] In the United States, it costs about US$0.05 per dose.[2]

  1. ^ "Ibuprofen". Retrieved 12 January 2016.
  2. ^ "Ibuprofen". The American Society of Health-System Pharmacists. Retrieved 12 October 2016.

Ifosfamide[edit]

The wholesale cost in the developing world is about US$7.35–70.70 per 2 gm vial.[1] In the UK this dose costs the NHS about 130.04 pounds.[2]

  1. ^ "Ifosfamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 580

Imipenem/cilastatin[edit]

The wholesale cost in the developing world is about US$12.68 to $60 per day.[1] In the United States it costs more than $200 for a course of treatment.[2]

  1. ^ "Imipenem + Cilastatin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015

Influenza vaccine[edit]

The wholesale price in the developing world is about US$5.25 per dose as of 2014.[1] In the United States, the vaccine costs less than US$25 per dose, as of 2015.[2]

<<Extensive discussion of cost-effectiveness and costs in countries worldwide>>

  1. ^ "Vaccine, influenza". International Drug Price Indicator Guide. Retrieved December 6, 2015.
  2. ^ TarasconPP2015, page 314

Insulin (medication)[edit]

The wholesale cost in the developing world is about US$2.39 to $10.61 per 1,000 iu (34.7 mg) of regular insulin and $2.23 to $10.35 per 1,000 iu of NPH insulin.[1][2] In the United Kingdom 1,000 iu of regular or NPH insulin costs the NHS £7.48, while this amount of insulin glargine costs £30.68.[3]

<<Extensive discussion costs in countries worldwide>>

  1. ^ "Insulin, Neutral Soluble". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Insulin, isophane". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  3. ^ BNF69, pages 464–472

Insulin aspart[edit]

In the United Kingdom it costs the NHS about £1.89 per 100 units as of 2019.[1] In the United States the wholesale cost of this amount is about US$30.00.[2]

  1. ^ BNF76, page 697
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Insulin detemir[edit]

In the United Kingdom it costs the NHS about £2.80 per 100 units as of 2019.[1] In the United States the wholesale cost of this amount is about US$29.50.[2]

  1. ^ BNF76, page 701
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Insulin glargine[edit]

In the United States the wholesale cost per 100 units is about US$26 USD as of 2018.[1] In the United Kingdom this amount costs the NHS about £2.35.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 701

Insulin lispro[edit]

In the United Kingdom it costs the NHS about £1.89 per 100 units as of 2019.[1] In the United States the wholesale cost of this amount is about US$30.00.[2]

Cost[edit]

In the United States, in 2015, the cost was between $10.06 and $29.36 per 100 units.[3] In April of 2019, Eli Lilly and Company announced they would produce a version selling for $137.35 per vial, about half the current cost. The chief executive said that this was a contribution "to fix the problem of high out-of-pocket costs for Americans living with chronic conditions", but Patients for Affordable Drugs Now said this was just a public relations move, as "other countries pay $20 for a vial of insulin.”[4] The cost in the UK was between £1.66 (about $2.50) and £1.96 (about $3.00) per 100 units, in 2017.[5]

  1. ^ BNF76, page 698
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Langreth, Robert (June 29, 2016). "Decoding Big Pharma's Secret Drug Pricing Practices". Bloomberg. Retrieved 15 July 2016.
  4. ^ "Drug company announces new version of insulin at half the price". The Hill. 3 April 2019. Retrieved 15 April 2019.
  5. ^ "Humalog | MIMS online". www.mims.co.uk. Retrieved 2017-01-12.

Intravenous sodium bicarbonate[edit]

The wholesale cost in the developing world is about US$0.09–2.58 per 10 ml of 8.4% solution.[1] In the United Kingdom this amount costs the NHS about 11.10 pounds.[2]

  1. ^ "Sodium Bicarbonate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 684

Intravenous sugar solution[edit]

The wholesale cost in the developing world is about US$1.00–1.80 per liter of 10% dextrose in water, and it is about US$0.60–2.40 per liter of 5% dextrose in normal saline.[1][2] In the United Kingdom a 50 ml vial of 50% solution costs the NHS 2.01 pounds.[3]

  1. ^ "Dextrose 10% in Water". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ "Dextrose 5% in Sodium Chloride 0.9%". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  3. ^ BNF69, pages 683–684

Iohexol[edit]

The wholesale cost in the developing world is about US$10.99 per 50 ml vial.[1] In the United States a dose costs US$50–100.[2]

  1. ^ "Iohexol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 171

Ipratropium bromide[edit]

The wholesale price in the developing world is about 6.60 USD for a 200 dose inhaler.[1] In the United States, a month worth of medication costs 100 to 200 USD.[2]

  1. ^ "Ipratropium Bromide". International Drug Price Indicator Guide. Retrieved 5 December 2015.[permanent dead link]
  2. ^ TarasconPP2015, page 455

Ipratropium bromide/salbutamol[edit]

Sixty doses in the United Kingdom costs the NHS about 18 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$9.50.[2]

  1. ^ BNF76, page 247
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Irbesartan[edit]

A month supply in the United Kingdom costs the NHS less than two pounds as of 2019.[1] In the United States the wholesale cost of this amount is about six dollars.[2]

  1. ^ BNF76, page 175
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Iron supplement[edit]

The wholesale cost in the developing world is about US$0.05–0.63 per month.[1] In the United States a typical month of treatment costs less than $25.[2]

  1. ^ "Ferrous Salt". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 217

Isoflurane[edit]

The wholesale cost in the developing world is about US$17.24–170.40 per 250 ml bottle.[1]

  1. ^ "Isoflurane". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Isoniazid[edit]

The wholesale cost in the developing world is about US$0.60–4.75 per month.[1] In the United States a month of treatment costs less than $25.[2]

  1. ^ "Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 49

Isoniazid/rifampicin[edit]

The wholesale cost in the developing world is about US$5.10 a month.[1] In the United Kingdom a month of medication costs the NHS about 28.11 pounds.[2]

  1. ^ "Rifampicin + Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 403

Isosorbide dinitrate[edit]

The wholesale cost in the developing world is about US$6.36 a month.[1] In the United States it costs less than US$25 per month.[2]

  1. ^ "Isosorbide Dinitrate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 160

Isosorbide mononitrate[edit]

A month supply in the United Kingdom costs the NHS about one £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.30.[2]

  1. ^ BNF76, pages 219–220
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Itraconazole[edit]

The wholesale cost in the developing world is about 0.29 USD per day of treatment as of 2015.[1] In the United States, as of 2017, the wholesale cost of this dose is 6.36 USD.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ "NADAC as of 2017-12-06". Centers for Medicare and Medicaid Services. Retrieved 10 December 2017.

Ivermectin[edit]

The wholesale cost in the developing world for the tablets is about US$0.12 for a course of treatment.[1] In the United States, the costs is less than US$50.[2][3]

Ivermectin is more effective than albendazole and equally as effective as thiabendazole for treatment of threadworm (strongyloidiasis). Ivermectin has fewer adverse effects than does thiabendazole and is at least as well tolerated as albendazole.[4] An analysis based on an economic model suggests that it is cost effective for people moving to Europe from areas where threadworm is common to be given a single-dose of ivermectin on arrival so as to cure presumptive infection with threadworm.[5] Persons who are immunocompromised or who will receive immunosuppressive treatment and who have confirmed or presumptive threadworm infestation are likely to benefit from treatment with ivermectin.[6]

Cost[edit]

The wholesale cost in the developing world is about US$0.12 for a course of treatment as of 2014.[1] This is down from an initial cost of US$6 proposed by Merck in 1987.[7]

In the United States a course of treatment with pills costs about US$25–50 for a typical adult.[2] As of 2019 ivermectin tablets were the least expensive treatment option for lice in children at about US$10.[8] The hair lotion, however, is about US$300 for a course of treatment.[8]

  1. ^ a b "Ivermectin". International Drug Price Indicator Guide. Retrieved January 16, 2016.
  2. ^ a b TarasconPP2014, page 40
  3. ^ "NADAC as of 2019-09-25 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 26 September 2019.
  4. ^ Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC, Terashima A, Samalvides F, Pérez-Molina JA, Plana MN (January 2016). "Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection". The Cochrane Database of Systematic Reviews (1): CD007745. doi:10.1002/14651858.CD007745.pub3. PMC 4916931. PMID 26778150.
  5. ^ Agbata EN, Morton RL, Bisoffi Z, Bottieau E, Greenaway C, Biggs BA, Montero N, Tran A, Rowbotham N, Arevalo-Rodriguez I, Myran DT, Noori T, Alonso-Coello P, Pottie K, Requena-Méndez A (December 2018). "Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review". Int J Environ Res Public Health. 16 (1): 11. doi:10.3390/ijerph16010011. PMC 6339107. PMID 30577567.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Kotton, Camille; Mileno, Maria; Keystone, J. (2019). "The Immunocompromised Traveler". Travel medicine. Edinburgh: Elsevier. pp. 269–277. ISBN 978-0-323-54696-6.
  7. ^ Crump, A; Ōmura, S (2011). "Ivermectin, 'wonder drug' from Japan: the human use perspective". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 87 (2): 13–28. Bibcode:2011PJAB...87...13C. doi:10.2183/pjab.87.13. PMID 21321478.
  8. ^ a b Kliegman, Robert M.; Geme, Joseph St (2019). Nelson Textbook of Pediatrics E-Book. Elsevier Health Sciences. p. 3575. ISBN 9780323568883.

Kanamycin A[edit]

The wholesale cost in the developing world is US$0.85–1.52 per dose as of 2014.[1]

  1. ^ "Kanamycin Sulfate". International Drug Price Indicator Guide. Retrieved 7 December 2016.

Ketamine[edit]

The wholesale price in the developing world is between US$0.84 and US$3.22 per vial.[1]

  1. ^ "Ketamine". Retrieved 12 January 2016.

Ketoconazole[edit]

A 30-gram tube in the United Kingdom costs the NHS less than £5 as of 2019.[1] In the United States, where the topical cream is available only by prescription, the wholesale cost of this amount is about US$6.30.[2]

  1. ^ BNF76, page 1198
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ketorolac[edit]

In the United Kingdom it costs the NHS less than £1 per injectable dose as of 2019.[1] In the United States the wholesale cost of this amount is about US$1.50.[2]

  1. ^ BNF76, pages 1144, 1302–1303
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Labetalol[edit]

A month supply in the United Kingdom costs the NHS about 8 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.[2]

  1. ^ BNF76, pages 147–148
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Lactulose[edit]

In various countries it could be purchased for about US$0.16 per 15 ml of syrup (10 g of lactulose) in 2015.[1][2] In the United States, the cost of this amount is about US$0.63.[3]

Cost[edit]

The wholesale price is about US$0.18 per 15-ml dose.[4] In the United States, 30 doses of the liquid cost about $20.[3]

  1. ^ "Lactulose". mshpriceguide.org. Retrieved 26 March 2017.
  2. ^ "Lactulose Solution 500ml". Weldricks Pharmacy (UK). Retrieved 31 March 2017. A UK source of lactulose at £2.95 for 500 ml ($0.11/15 ml).
  3. ^ a b "Lactulose Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 25 March 2017. Source gives cost for 473 ml as about $20.
  4. ^ "Lactulose". International Drug Price Indicator Guide. Retrieved 11 August 2015.

Lamivudine[edit]

The wholesale cost in the developing world as of 2014 is about US$0.06 per day.[1] As of 2015 the cost for a typical month of medication in the United States is more than $200.[2]

History[edit]

As of 2015 the cost for a typical month of medication in the United States is more than $200.[3]

  1. ^ "Lamivudine". International Drug Price Indicator Guide. Retrieved 23 July 2016.
  2. ^ TarasconPP2015, page 65
  3. ^ TarasconPP2015, page 65

Lamivudine/nevirapine/stavudine[edit]

The wholesale cost in the developing world is about 9.56 USD per month.[1]

  1. ^ "Lamivudine + Stavudine + Nevirapine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Lamivudine/nevirapine/zidovudine[edit]

The wholesale cost in the developing world is about 8.54 to 18.94 USD a month as of 2014.[1]

  1. ^ "Lamivudine + Zidovudine + Nevirapine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Lamivudine/zidovudine[edit]

The wholesale cost in the developing world is about US$6.90 to $29.64 per month.[1] As of 2015 the cost for a typical month of medication in the United States more than $200.[2]

Society and culture[edit]

  1. Combivir: lamivudine 150 mg and zidovudine 300 mg (scored). 60 tablets cost $994.[3]
  1. ^ "Lamivudine + Zidovudine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 59
  3. ^ "The Cost of HIV Treatment". 2015-04-02. Retrieved 2016-11-16.

Lamotrigine[edit]

The wholesale cost in the developing world is about US$3.50 to US$23 per month as of 2015.[1] In the United States, this amount has a wholesale cost of about US$4.60 as of 2019.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ "NADAC as of 2019-11-27 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 26 November 2019.

Lansoprazole[edit]

A one month supply, in the United Kingdom, costs the NHS less than £5, as of 2019.[1] In the United States, the wholesale cost of this amount is about $5.40, as of 2019.[2]

  1. ^ BNF76, pages 79–80
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Latanoprost[edit]

The wholesale cost in the developing world is about US$0.69–3.79 per 2.5 ml bottle.[1] In the United States a month of treatment costs less than $25.[2]

  1. ^ "Latanoprost". International Drug Price Indicator Guide. Retrieved 8 December 2016.[permanent dead link]
  2. ^ TarasconPP2015, page 413

Lenalidomide[edit]

In the United States it costs about US$16,000 to US$21,000 per month as of 2019.[1] In the United Kingdom this amount costs the NHS about £3,400 to 4,400.[2]

Price[edit]

Lenalidomide costs $163,381 per year for the average person in the United States.[3]

  1. ^ "Revlimid Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 27 October 2019.
  2. ^ BNF76, page 935
  3. ^ Badros AZ (10 May 2012). "Lenalidomide in Myeloma — A High-Maintenance Friend". N Engl J Med. 366 (19): 1836–1838. doi:10.1056/NEJMe1202819. PMID 22571206.

Levamisole[edit]

The wholesale cost in the developing world is about US$0.18 to US$0.33 for a course of treatment.[1]

  1. ^ "Levamisole". International Drug Price Indicator Guide. Retrieved 1 December 2016.

Levetiracetam[edit]

A month supply in the United Kingdom costs the NHS about £19.31 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.50.[2]

  1. ^ BNF76, page 319
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Levocetirizine[edit]

A month supply in the United Kingdom costs the NHS about 4.50 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$3.[2]

  1. ^ BNF76, pages 280–281
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Levofloxacin[edit]

The wholesale cost in the developing world is about US$0.44–0.95 per week of treatment.[1] In the United States a week of treatment costs about $50–100.[2]

  1. ^ "Levofloxacin". International Drug Price Indicator Guide. Retrieved August 25, 2016.
  2. ^ TarasconPP2015, page 102

Levonorgestrel[edit]

The wholesale cost in the developing world is between $0.23 and $1.65 US for the dose required for emergency birth control.[1]

  1. ^ "Levonorgestrel". International Drug Price Indicator Guide. Retrieved 21 August 2015.

Levonorgestrel-releasing implant[edit]

The wholesale cost in the developing world is about US$8.93–13.29 per set.[1]

  1. ^ "Levonorgestrel". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Levothyroxine[edit]

The wholesale cost in the developing world is about US$0.58 to US$12.28 per month.[1] In the United States, a typical month of treatment costs less than US$25.[2]

  1. ^ "Levothyroxine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 223

Lidocaine[edit]

It is available as a generic medication and is not very expensive.[1][2] The wholesale cost in the developing world in 2014 was US$0.45 to $1.05 wholesale per 20 ml vial of medication.[3]

  1. ^ "Lidocaine Hydrochloride (Local)". The American Society of Health-System Pharmacists. Retrieved Aug 26, 2015.
  2. ^ TarasconPP2015, page 22
  3. ^ "Lidocaine HCL". International Drug Price Indicator Guide. Retrieved 27 August 2015.

Linagliptin[edit]

A month supply in the United Kingdom costs the NHS about £33.26 as of 2019.[1] In the United States the wholesale cost of this amount is about 391 USD.[2]

  1. ^ BNF76, page 680
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Liothyronine[edit]

A month's supply in the United Kingdom costs the NHS about £247 as of 2019.[1] In the United States the wholesale cost of this amount is about US$22.40.[2]

Pricing[edit]

The British Competition and Markets Authority launched an investigation into the alleged "excessive and unfair pricing" of liothyronine tablets in 2017. It alleged that Advanz Pharma overcharged the NHS from before 2007 to July 2017. The price of a pack increased by almost 1,600% from £4.46 before it was debranded in 2007 to £258.19 by July 2017.[3]

  1. ^ BNF76, page 757
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "CMA investigates 1,600% price increase of liothyronine over eight-year period". Pharmaceutical Journal. 31 January 2019. Retrieved 17 March 2019.

Liraglutide[edit]

A month supply in the United Kingdom costs the NHS about £78.50 as of 2019.[1] In the United States the wholesale cost of this amount is about US$98.30.[2]

  1. ^ BNF76, page 685
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Lisdexamfetamine[edit]

A month supply in the United Kingdom costs the British National Health Service about £58 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$264.[2]

  1. ^ BNF76, pages 348–349
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Lisinopril[edit]

In the United States the wholesale cost per month was less than 0.70 USD as of 2018.[1] In the United Kingdom it cost the NHS about 10 pounds per month as of 2018.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 170

Lisinopril/hydrochlorothiazide[edit]

In the United States the wholesale cost per dose is less than US$0.05 as of 2018.[1] In the United Kingdom it costs the NHS about 0.40 pounds per dose as of 2017.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF74, page 166

Lithium (medication)[edit]

The wholesale cost in the developing world in 2014 was between 0.12 and 0.20 USD per day.[1] In the United States at usual doses it costs about 0.90 to 1.20 USD per day.[2]

  1. ^ "Lithium Carbonate". International Drug Price Indicator Guide. Retrieved 1 December 2015.
  2. ^ "Lithium Salts". The American Society of Health-System Pharmacists. Retrieved Dec 1, 2015.

Loperamide[edit]

Loperamide is available as an inexpensive generic medication.[1][2] The wholesale cost in the developing world is about US$0.004 to 0.040 per dose.[3] In August 2016, the US retail cost is about US$0.31 per dose.[4]

Cost[edit]

It is sold as a generic medication and is not very expensive.[1][2] The wholesale cost in the developing world is about US$0.004 to 0.040 a dose.[3] In August 2016, the US retail cost is about $0.31 per dose.[4]

  1. ^ a b "Loperamide Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 25 August 2015.
  2. ^ a b TarasonPP2013, page 217
  3. ^ a b "Loperamide HCL". International Drug Price Indicator Guide. Retrieved 26 August 2015.
  4. ^ a b "NADAC (National Average Drug Acquisition Cost) Loperamide". Centers for Medicare and Medicaid Services. Retrieved 16 April 2016. Loperamide 2mg Capsule ... 0.33803 [USD] ... 03/23/2016

Lopinavir/ritonavir[edit]

The wholesale cost in the developing world is 18.96 to 113.52 a month.[1] In the United States it is not available as a generic medication and costs more than US$200 for a typical month supply as of 2016.[2]

  1. ^ "Lopinavir + Ritonavir". International Drug Price Indicator Guide. Retrieved 28 November 2016.
  2. ^ TarasconP2016, page 67

Loratadine[edit]

The wholesale cost in the developing world is about US$0.01 to 0.06 per dose as of 2015.[1]

  1. ^ "Loratadine". International Drug Price Indicator Guide. Retrieved 1 June 2018.

Lorazepam[edit]

The wholesale cost in the developing world of 1 mg dose by mouth is about US$0.02 to US$0.21 as of 2015.[1] This amount in the United Kingdom costs the NHS about £0.14.[2] In the United States as of 2015 a typical month's supply is less than US$25.[3]

  1. ^ "Lorazepam". International Medical Products Price Guide. Retrieved 29 November 2019.
  2. ^ BNF76, page 336
  3. ^ TarasconPP2015, page 437

Losartan[edit]

The wholesale cost in the developing world is about US$0.28–3.45 per month as of 2015.[1] In the United States, as of 2017, the wholesale cost of a typical dose is $1.13 per month.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ "NADAC as of 2017-12-06". Centers for Medicare and Medicaid Services. Retrieved 10 December 2017.

Losartan/hydrochlorothiazide[edit]

A month supply in the United Kingdom costs the NHS about 1.50 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.50.[2]

  1. ^ BNF76, page 176
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Lovastatin[edit]

In the United States the wholesale cost is about 0.05 USD per dose.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Lurasidone[edit]

A month supply in the United Kingdom costs the NHS about £90.72 as of 2019.[1] In the United States the wholesale cost of this amount is about US$190.20.[2]

  1. ^ BNF76, pages 393–394
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Macrogol[edit]

In the United Kingdom it costs the NHS about £0.14 per dose as of 2019.[1] In the United States the wholesale cost of this amount is about US$1.40.[2]

  1. ^ BNF76, pages 57–58
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Magnesium sulfate (medical use)[edit]

The wholesale cost in the developing world is about US$0.35–8.73 per 10 ml of 50% solution.[1] In the United Kingdom 4 ml of 20% solution costs the NHS about 10.23 pounds.[2] In the United States a course of medication typically costs less than $25.[3]

  1. ^ "Magnesium Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 696
  3. ^ TarasconPP2015, page 220

Mannitol[edit]

The wholesale cost in the developing world is about 1.12 to US$5.80 per dose.[1] In the United States, a course of treatment costs $25 to $50.[2]

  1. ^ "Mannitol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 344

Measles vaccine[edit]

The wholesale cost in the developing world is about 0.70 USD per dose as of 2014.[1]

  1. ^ "Vaccine, Measles". International Drug Price Indicator Guide. Retrieved 6 December 2015.

Mebendazole[edit]

The wholesale cost in the developing world is between USD 0.004 and 0.04 per dose.[1] In the United States a single dose is about USD 440.00 as of 2016, while in Australia and the UK it costs about USD 5.00.[2]

Cost[edit]

In the developing world the wholesale cost is between USD 0.004 and 0.04 per dose as of 2014.[1] In the United States a single dose was about USD 18.00 in 2015.[3] In 2016 the price increased to USD 440.00 per dose in the U.S. as Amedra Pharmaceuticals acquired the rights from Teva in 2013.[2]

  1. ^ a b "Mebendazole". International Drug Price Indicator Guide. Retrieved 18 August 2015.
  2. ^ a b Crow, David (18 December 2016). "US drugmaker charges 200 times UK price for common worm pill". www.ft.com. Retrieved 8 January 2017.
  3. ^ "Mebendazole". The American Society of Health-System Pharmacists. Retrieved Aug 18, 2015.

Meclizine[edit]

In the United States the wholesale cost per dose is about US$0.03.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Medroxyprogesterone acetate[edit]

The wholesale cost in the developing world is about US$0.59–1.57 per vial.[1] In the United Kingdom this dose costs the NHS about 6.01 pounds.[2] In the United States it costs less than $25 a dose as of 2015.[3]

  1. ^ "Medroxyprogesterone Acetate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 555
  3. ^ TarasconPP2015, page 363

Mefloquine[edit]

The wholesale price in the developing world is about US$0.6–1.3 per dose.[1] In the United Kingdom it costs the NHS £1.82 per dose.[2] In the United States it costs about $10 a dose.[3]

  1. ^ "Mefloquine". International Drug Price Indicator Guide. Retrieved 27 November 2015.
  2. ^ BNF76, page 607
  3. ^ "Mefloquine Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 27 Nov 2015.

Meglumine antimoniate[edit]

The wholesale cost in the developing world is about 4.32 USD per vial as of 2014.[1]

  1. ^ "Meglumine Antimonate". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Meloxicam[edit]

In the United States the wholesale cost per dose is less than US$0.02 as of 2018.[1] In the United Kingdom it costs about 0.13 pounds as of 2018.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare & Medicaid Services (CMS). Retrieved 22 December 2018.
  2. ^ BNF76, pages 1112–1113

Melphalan[edit]

In the United Kingdom it costs the NHS £137 per 50 mg vial.[1] In the United States the cost of this amount is US$257.[2]

  1. ^ BNF76, pages 873–874
  2. ^ "Melphalan Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 27 October 2019.

Memantine[edit]

A month supply in the United Kingdom costs the NHS about 1.60 GBP as of 2019.[1] In the United States the wholesale cost of this amount is about US$5.50.[2]

History[edit]

The cost of Namenda was $269 to $489 a month in 2012.[3]

  1. ^ BNF76, pages 303–304
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "Evaluating Prescription Drugs Used to Treat: Alzheimer's Disease. Comparing Effectiveness, Safety, and Price" (PDF). Consumer Reports Health. May 2012.

Meningococcal vaccine[edit]

The wholesale cost in the developing world is between US $3.23 and $10.77 per dose as of 2014.[1] In the United States it costs $100–200 for a course.[2]

  1. ^ "Vaccine, Meningococcal". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 315

Mercaptopurine[edit]

The wholesale cost in the developing world is about US$18.42–200.16 a month.[1] In the United Kingdom this costs the NHS about 121.13 pounds per month.[2] In the United States the wholesale cost is about $99.16 per month as of 2016.[3]

  1. ^ "Mercaptopurine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 590
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 21 December 2016.

Meropenem[edit]

The wholesale cost in the developing world is between 3.44 and 20.58 USD per one gram vial as of 2015.[1] In the United Kingdom this amount costs the NHS about £16 in 2015.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ BNF69, page 379

Meropenem/vaborbactam[edit]

In the United States it costs about US$1,126 per day as of 2019.[1]

  1. ^ "Vabomere Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 6 November 2019.

Mesalazine[edit]

A month supply in the United Kingdom costs the NHS about £43 as of 2019.[1] In the United States the wholesale cost of this amount is about 288 USD.[2]

  1. ^ BNF76, pages 39-41
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Mesna[edit]

The wholesale cost in the developing world is about US$3.50 per 400 mg vial.[1] In the United Kingdom this amount costs the NHS about £3.95.[2]

  1. ^ "Mesna". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 578

Metformin[edit]

The wholesale price in the developed world was between US$0.21 and $5.55 per month as of 2014.[1] In the United States, it costs US$5 to US$25 per month.[2]

  1. ^ "Metformin". Retrieved 11 January 2016.
  2. ^ "Metformin Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 2 January 2017.

Methocarbamol[edit]

A month supply in the UK costs the NHS about £12.72 as of 2019.[1] In the US the wholesale cost of this quantity is about US$6.50.[2]

  1. ^ BNF76
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Methotrexate[edit]

The wholesale cost as of 2014 in the developing world is between US$0.06 and US$0.36 per day for the form taken by mouth.[1] In the United States, a typical month of treatment costs $25 to $50.[2]

  1. ^ "Methotrexate Sodium". International Drug Price Indicator Guide. Retrieved 23 August 2016.
  2. ^ TarasconPP2015, page 464

Methyldopa[edit]

The wholesale cost in the developing world is about US$4.31–9.48 per month.[1] In the United States it costs less than $25 per month.[2]

  1. ^ "Methyldopa". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 140

Methylene blue[edit]

In the United States, a 50 mg vial costs about 191.40 USD.[1] In the United Kingdom, a 50 mg vial costs the NHS about £39.38.[2]

  1. ^ "Provayblue Prices, Coupons & Patient Assistance Programs - Drugs.com". www.drugs.com. Retrieved 12 January 2017.
  2. ^ BNF69, page 34

Methylphenidate[edit]

In the United States, the wholesale cost of the immediate release formulation is less than US$0.30 per dose as of 2018.[1]

Cost[edit]

Generic immediate-release methylphenidate is relatively inexpensive. The average wholesale cost is about US$0.15 per defined daily dose (retail pharmacies normally charge more).[2] However, the most expensive brand-name extended-release tablets may retail for as much as $12.40 per defined daily dose.[3]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 19 December 2018.
  2. ^ Based on: "Methylphenidate Hydrochloride". International Drug Price Indicator Guide. Retrieved 9 May 2016.
  3. ^ The Ontario Drug Benefit online formulary indicates that, in Ontario, Canada, the local most-expensive methylphenidate product is probably Concerta. Drug prices in the US are often higher than in Canada. The GoodRx website correctly points out that short-term refills (e.g. 30 tablets) often cost more per tablet than longer-term refills (e.g. 90 tablets). For 30 tablets of brand-name Concerta 27 mg, the relevant GoodRx webpage Archived 5 June 2016 at the Wayback Machine offers coupons. However, if a patient ignores the coupons, and if the patient does not shop around, the website indicates that it is possible to pay more than twelve US dollars per defined daily dose. Data retrieved 17 May 2016.

Methylprednisolone[edit]

The wholesale cost in the developing world is about US$3.81–9.35 per 500 mg vial.[1] In the United States, a course of treatment typically costs less than $25.[2]

  1. ^ "Methylprednisolone". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 202

Metoclopramide[edit]

The wholesale cost in the developing world as of 2014 is US$0.003 to US$0.08 per pill.[1] In the United States a month worth of medication is generally less than US$25.[2]

  1. ^ "Metoclopramide HCL". International Drug Price Indicator Guide. Retrieved 23 August 2016.
  2. ^ TarasconPP2015, page 262

Miconazole[edit]

The wholesale cost in the developing world is about 0.23 to US$0.60 for a 30 gram tube.[1] In the United States a course of treatment costs less than US$25.[2]

  1. ^ "Miconazole Nitrate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 180

Midazolam[edit]

Midazolam is available as a generic medication and is not very expensive.[1] The wholesale cost in the developing world of a vial is about US$0.35.[2]

Cost[edit]

Midazolam is available as a generic medication and is not very expensive.[1] The wholesale price of a vial is about US$0.35.[2]

  1. ^ a b TarasconPP2015, page 21
  2. ^ a b "Midazolam". International Drug Price Indicator Guide. Retrieved 29 August 2015.

Minocycline[edit]

A month supply in the United Kingdom costs the NHS about 14 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.[2]

Cost[edit]

A month supply in the United Kingdom costs the NHS about 14 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.[2] In October 2015, a bottle of 30 of tablets of one brand cost $1,040.41 wholesale.[3] Expensive medications like this were sold through the specialty pharmacy Philidor by Valeant Pharmaceuticals International Inc in a 2015 controversial legal tangle involving both companies.[4][5]

  1. ^ a b BNF76, page 556
  2. ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Rockoff, Jonathan D.; Whalen, Jeanne (28 October 2015). "Pharmacy's Sales Tactics Disclosed". Dow Jones News. Retrieved 1 November 2015.
  4. ^ Rapoport, Michael (29 October 2015). "Valeant Countersues R&O Pharmacy Billing dispute draws attention to drug maker's work with specialty pharmacies". The Wall Street Journal.
  5. ^ Dulaney, Chelsey (May 6, 2015). "Alexion to Buy Synageva for $8.4 Billion". The Wall Street Journal.

Mirabegron[edit]

A month supply in the United Kingdom costs the NHS about £29 as of 2019.[1] In the United States the wholesale cost of this amount is about 369 USD.[2]

  1. ^ BNF76, page 763
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Mirtazapine[edit]

In the United States the wholesale cost as of 2018 is about US$3 per month.[1] In the United Kingdom a month supply costs less than £20 per month.[2]

  1. ^ "NADAC as of 2018-11-21". Centers for Medicare and Medicaid Services. Retrieved 21 November 2018.
  2. ^ BNF74, page 354

Misoprostol[edit]

The wholesale cost in the developing world is about 0.36 to 2.00 USD a dose.[1] A month's supply to treat stomach ulcers in the United States is between 100 and 200 USD.[2] The same costs between 30 and 55 EUR in Europe.[3]

  1. ^ "Misoprostol". International Drug Price Indicator Guide. Retrieved 20 December 2015.
  2. ^ TarasconPP2015, page 271
  3. ^ "DocMorris - Cytotec 200 µg Tabletten". 6 May 2016. Retrieved 20 May 2016.

Modafinil[edit]

In the United Kingdom it costs the NHS about £105.21 a month as of 2018.[1] In the United States the wholesale cost per month is about US$34.20 as of 2018.[2]

  1. ^ BNF74, page 468
  2. ^ "NADAC as of 2018-06-13". Centers for Medicare and Medicaid Services. Retrieved 24 June 2018.

Mometasone/formoterol[edit]

In the United States the wholesale cost of a puffer is about 202 USD as of 2019.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Monochloramine[edit]

The wholesale cost in the developing world is about US$13.80 to US$18.41 per 500 grams.[1]

  1. ^ "Chloramine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Montelukast[edit]

In the United States, the wholesale cost per dose is less than 0.15 USD as of 2018.[1] In the United Kingdom, it costs the NHS about a pound per dose.[2] In 2016, it was the 23rd most prescribed medication in the United States, with more than 25 million prescriptions.[3]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 269
  3. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Moxifloxacin[edit]

The wholesale cost in the developing world is US$0.45–2.70 per day, as of 2015.[1] In the United States, as of 2017, the wholesale cost is about $4.00 per day.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ "NADAC as of 2017-12-06". Centers for Medicare and Medicaid Services. Retrieved 10 December 2017.

Mumps vaccine[edit]

The wholesale cost in the developing world of the version that includes measles and rubella is 0.24 USD per dose as of 2014.[1]

  1. ^ "Vaccine, Measles-Mumps-rubella". International Drug Price Indicator Guide. Retrieved 8 December 2015.

Mupirocin[edit]

The wholesale cost in the developing world is about US$2.10 for a 15 g tube.[1] In the United States, a course of treatment costs $25 to $50.[2]

  1. ^ "Mupirocin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 178

Mycophenolic acid[edit]

In the United Kingdom it costs the NHS about £14 per month.[1] In the United States this amount is about US$114.[2]

  1. ^ BNF76, pages 826–827
  2. ^ "Mycophenolate mofetil Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 29 October 2019.

NPH insulin[edit]

The wholesale cost in the developing world is about US$2.23–10.35 per 1,000 iu of NPH insulin.[1] In the United Kingdom 1,000 iu of NPH insulin costs the NHS £7.48 while in the United States this amount costs about US$134.00.[2][3]

  1. ^ "Insulin, Neutral Soluble". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 464–472
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 17 January 2017.

Nadolol[edit]

A month supply in the United Kingdom costs the NHS about £6 as of 2019.[1] In the United States the wholesale cost of this amount is about $US 52 .[2]

  1. ^ BNF76, page 148
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Naloxone[edit]

Its wholesale price in developing countries is between $0.50 and $5.30 per dose.[1] Vials of naloxone are not very expensive (less than $25) in the United States.[2] However, the price for a package of two auto-injectors in the US has increased from $690 in 2014 to $4,500 in 2016.[3] The 2018 price for the NHS in the United Kingdom is about £5 per dose.[4] In Australia, a single dose without prescription costs AU$20 while with a prescription five doses is AU$40.[5]

  1. ^ "Naloxone HCL". International Drug Price Indicator Guide. Retrieved 13 August 2015.
  2. ^ TarasconPP2014, page 174
  3. ^ "Perspective: The Rising Price of Naloxone — Risks to Efforts to Stem Overdose Deaths". N Engl J Med. 375 (23): 2213–2215. December 8, 2016. doi:10.1056/NEJMp1609578. PMID 27959694. {{cite journal}}: Cite uses deprecated parameter |authors= (help)
  4. ^ BNF74, page 1260
  5. ^ Coulter, Ellen (27 August 2019). "This drug can temporarily reverse an opioid overdose. So why aren't people using it?". ABC News. Retrieved 28 August 2019.

Naltrexone[edit]

As of 2019, the wholesale cost of tablets is about US$0.78 per day in the United States.[1] The extended-release injections cost about $1,267 per month ($41.20 per day).[1]

  1. ^ a b "NADAC as of 2019-07-17 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 16 July 2019.

Naproxen[edit]

In the United Kingdom, it cost about £0.15 per dose in 2017.[1] In the United States, the wholesale cost per dose is less than US$0.10 as of 2018.[2]

  1. ^ BNF74, pages 1048–1049
  2. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Natamycin[edit]

The wholesale cost in the developing world is between US$92.90 and 126.72 per 5-ml bottle as of 2015.[1]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.

Nebivolol[edit]

A month supply in the United Kingdom costs the NHS about 0.89 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$128.00.[2]

  1. ^ BNF76, page 154
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Neomycin/polymyxin B/hydrocortisone[edit]

In the United Kingdom a 10 ml bottle costs the NHS about £7.45 as of 2019.[1] In the United States the wholesale cost of this amount is about 50 USD.[2]

Cost[edit]

In David Lazarus' February 4, 2016 LA Times column, a pharmacist recalled a 10 milliliter vial of the drug selling for around $10 in the early 2010s. In 2015, the price was $100, and in 2016, it reportedly was selling for $195. A generic version is priced at $144.[3]

  1. ^ BNF76, page 1164
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Lazarus, David (2016-02-04). "Martin Shkreli isn't alone in ripping off patients with crazy drug prices". latimes.com. Retrieved 2016-02-05.

Neostigmine[edit]

The wholesale cost in the developing world is about US$0.18–2.6 per dose.[1]

  1. ^ "Neostigmine Methylsulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Nepafenac[edit]

Cost[edit]

The average yearly cost for a Medicare Part D patient for Ilevro is $94.[1] The estimated per unit price in the United States for Nevanac is $88.93.[2] For Ilevro, the per unit price for the 1.7 mL bottle averages $156.89 and the per unit price for the 3 mL bottle averages $88.91.[3] Average price for both drugs is similar.[2][3]

  1. ^ Cite error: The named reference ProPublica Ilevro was invoked but never defined (see the help page).
  2. ^ a b "Nevanac Prices, Coupons and Patient Assistance Programs". Drugs.com. Retrieved October 31, 2017.
  3. ^ a b "Ilevro Prices, Coupons and Patient Assistance Programs". Drugs.com. Retrieved October 31, 2017.

Nevirapine[edit]

The wholesale cost in the developing world is US$2.16 to $16.62 per month as of 2014.[1] As of 2015, the cost for a typical month of medication in the United States was more than $200.[2]

  1. ^ "Nevirapine". International Drug Price Indicator Guide. Retrieved 3 December 2016.
  2. ^ TarasconPP2015, page 63

Niclosamide[edit]

The wholesale cost in the developing world is about 0.24 USD for a course of treatment.[1]

  1. ^ "Niclosamide". International Drug Price Indicator Guide. Retrieved 1 December 2016.

Nifedipine[edit]

The wholesale price in the developing world for the slow-release form is approximately US$1.90–3.80 per month.[1] In the United States, it costs approximately $40–60 per month, depending on the dose.Cite error: A <ref> tag is missing the closing </ref> (see the help page). In the United States this amount costs US$14,367.94 as of 2019.[2] In the United Kingdom it costs the NHS £2,432.85 per month as of 2018.[3] In the United States this amount costs US$14,367.94 as of 2019.[2]

  1. ^ "Nifedipine". International Drug Price Indicator Guide. Retrieved 25 December 2015.
  2. ^ a b "Tasigna Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 14 November 2019.
  3. ^ Cite error: The named reference NilotinibBNF76 was invoked but never defined (see the help page).

Nitrofurantoin[edit]

The wholesale cost in the developing world is between 0.10 and 9.20 USD for a course of treatment.[1] In the United States, the wholesale cost is about 8 USD for this amount as of 2018.[2]

Cost[edit]

The wholesale cost in the developing world is between 0.10 and 9.20 USD for a course of treatment.[1] In the United States, the wholesale cost is about 8 USD for this amount as of 2018.[2] The cost of the liquid formulation of nitrofurantoin in the U.S. became controversial after a 400% price increase. There are two manufacturers of the liquid formulation in the U.S., Casper Pharma and Nostrum Laboratories. In 2018, Casper increased their price to $2,800. In response to Casper, Nostrum increased their price from $474.75 to $2,392. In the U.K., a slightly larger bottle costs £446.95. In an interview with the Financial Times, Nirmal Mulye, Nostrum chief executive, said that there was a "moral requirement to sell the product at the highest price." He defended Martin Shkreli, and said, "This is a capitalist economy and if you can’t make money you can’t stay in business." Mulye also attacked the U.S. Food and Drug Administration as "incompetent and corrupt." There is a shortage of liquid nitrofurantoin, because the FDA implemented new rules on impurities, he said. Mulye dismissed the new rules on impurities as a "piece of nonsense."[3] FDA commissioner Scott Gottlieb tweeted a response: "[T]here’s no moral imperative to price gouge and take advantage of patients. FDA will continue to promote competition so speculators and those with no regard to public health consequences can’t take advantage of patients who need medicine."[4]

  1. ^ a b "Nitrofurantoin". International Drug Price Indicator Guide. Retrieved 31 August 2015.
  2. ^ a b "NADAC as of 2018-09-12". Centers for Medicare and Medicaid Services. Retrieved 26 June 2018.
  3. ^ Pharma chief defends 400% drug price rise as a ‘moral requirement’, David Crow, Financial Times, Sept. 11, 2018
  4. ^ Hiltzik, Michael. "Drug executive: It's a 'moral requirement' to charge patients the highest price". latimes.com. Retrieved 14 September 2018.

Nitroglycerin (medication)[edit]

The wholesale cost in the developing world as of 2014, was US$0.06–0.22 per dose by mouth.[1]

  1. ^ "Nitroglycerin". 2014. Retrieved 8 December 2016.

Nivolumab[edit]

In the United Kingdom it costs the NHS about £5266 a month as of 2018.[1] In the United States this amount costs about US$13,556 as of 2019,[2] while in China it is about US$7,000.[3]

  1. ^ BNF76, page 852
  2. ^ "Opdivo Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 14 November 2019.
  3. ^ "Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report". Endpoints News. Retrieved 2019-09-09.

Norepinephrine (medication)[edit]

The wholesale cost in the developing world as of 2015 is about 0.42 USD per vial of four milligrams.[1] In the United Kingdom this amount costs the NHS about 4.40 pounds.[2]

  1. ^ "Norepinephrine". mshpriceguide.org. Retrieved 26 March 2017.
  2. ^ BNF69, page 145

Norethisterone enanthate[edit]

The wholesale cost in the developing world is about US$1.04–7.99 per 200 mg vial.[1]

  1. ^ "Norethisterone". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Nortriptyline[edit]

Nortriptyline was approved for medical use in the United States in 1964.[1] A month supply in the United Kingdom costs the NHS about £25.00 as of 2019.[2] In the United States the wholesale cost of this amount is about US$4.20.[3]

  1. ^ "Nortriptyline Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 22 March 2019.
  2. ^ BNF76, page 374
  3. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Nystatin[edit]

The wholesale price of the cream in the developing world is about US$0.70 per 30 gram tube.[1] In the United States a course of treatment costs less than US$25.[2]

  1. ^ "Nystatin". International Drug Price Indicator Guide. Retrieved 2016-01-27.
  2. ^ TarasconPP2015, page 180

Ofloxacin[edit]

The wholesale cost in the developing world is about US$3.27 per month.[1] In the United States, a course of treatment costs about $50–100.[2]

  1. ^ "Ofloxacin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 101

Olanzapine[edit]

In the United States, the wholesale cost is less than US$0.25 per dose as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Olmesartan[edit]

A month supply in the United Kingdom costs the NHS less than 2.50 £ as of 2019.[1] In the United States the wholesale cost of this amount is less than US$5.[2]

  1. ^ BNF76, page 177
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Olmesartan/hydrochlorothiazide[edit]

A month supply in the United Kingdom costs the NHS about 13 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$6.[2]

  1. ^ BNF76, pages 177–178
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Olopatadine[edit]

A 5 milliliter bottle of the eye drops in the United Kingdom costs the NHS less than £5 as of 2019.[1] In the United States the wholesale cost of this amount is about US$12.50.[2]

  1. ^ BNF76, page 1126
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Omega-3 acid ethyl esters[edit]

A one-month supply in the United Kingdom costs the NHS about £6 as of 2019.[1] In the United States the wholesale cost of this amount is about 7.50 USD.[2]

  1. ^ BNF76, pages 206–207
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Omeprazole[edit]

The wholesale cost in the developing world as of 2014 is US$0.01 to US$0.07 per dose.[1] In the United States, it costs on average US$0.50 per pill.[2]

  1. ^ "Omeprazole". International Drug Price Indicator Guide. Retrieved October 21, 2018.
  2. ^ "NADAC as of 2016-11-16 Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved October 21, 2018.

Ondansetron[edit]

The wholesale cost of the injectable form in the developing world is about US$0.10 to US$0.76 per dose.[1] In the United States it costs about US$1.37 per tablet.[2]

  1. ^ "Ondansetron". International Drug Price Indicator Guide. Retrieved 26 January 2016.
  2. ^ "Ondansetron Hydrochloride". The American Society of Health-System Pharmacists. Retrieved February 11, 2017.

Oral rehydration therapy[edit]

The wholesale cost in the developing world of a package to mix with a liter of water is US$0.03 to 0.20.[1]

  1. ^ "Oral Rehydration Salts". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Oseltamivir[edit]

As of 2014 the wholesale cost in the developing world was about US$4.27 per day.[1] The wholesale cost for a course of treatment in the United States is about US$54.00 as of 2019.[2]

  1. ^ "Oseltamivir". International Drug Price Indicator Guide. Retrieved 30 July 2016.
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Oxaliplatin[edit]

The wholesale cost in the developing world is 8.74 to 125.43 USD a vial.[1] In the United Kingdom it costs the NHS 299.50 pounds per 100 mg dose.[2]

  1. ^ "Oxaliplatin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 605

Oxcarbazepine[edit]

A month supply in the United Kingdom costs the NHS about 6.50 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$7.15.[2]

  1. ^ BNF76, pages 319–320
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Oxybutynin[edit]

A month supply in the United Kingdom costs the NHS less than GB£3 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$14.[2]

  1. ^ BNF76
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Oxycodone[edit]

In the United States, the wholesale cost per dose is less than US$0.30 as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Oxytocin (medication)[edit]

As of 2014, the wholesale cost in the developing world is US$0.10 to 0.56 per dose.[1]

  1. ^ "Oxytocin". International Drug Price Indicator Guide. Retrieved 20 December 2015.

Paclitaxel[edit]

The wholesale cost in the developing world is about US$7.06–13.48 per 100 mg vial.[1] This amount in the United Kingdom costs the NHS about 66.85 GBP.[2]

Cost[edit]

As of 2006, the cost to the NHS per patient in early breast cancer, assuming four cycles of treatment, was about £4000 (approx. $6000).[3]

  1. ^ "Paclitaxel". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 623
  3. ^ "NICE Guidance TA108".

Pancreatic enzymes (medication)[edit]

In the United Kingdom a typical month's supply costs the NHS about £12.93 to £47.55 as of 2019.[1] In the United States the wholesale cost of this amount is about US$300 to US$900.[2]

  1. ^ BNF76, pages 96–97
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Pantoprazole[edit]

As of 2018, the wholesale cost of the pills in the United States is less than US$0.10 per dose.[1] In the United Kingdom, this amount costs less than 0.05 pounds, while the intravenous formulation costs about 5 pounds per dose.[2]

  1. ^ "NADAC as of 2018-10-24". Centers for Medicare and Medicaid Services. Retrieved 28 October 2018.
  2. ^ BNF74, page 79

Paracetamol[edit]

The wholesale price in the developing world is less than US$0.01 per dose.[1] In the United States, it costs about US$0.04 per dose.[2]

Cost[edit]

The wholesale price in the developing world is less than US$0.01 per dose.[1] In the United States, it costs about US$0.04 per dose.[2] In Europe, prices differ from country to country; low-cost prices for 10 doses could reach €0.54 in Portugal, €0.91 in France and €1.97 in Germany.[3]

  1. ^ a b "Paracetamol". Retrieved 11 January 2016.
  2. ^ a b "Acetaminophen prices, coupons and patient assistance programs". Retrieved 19 February 2016.
  3. ^ "Les prix en Europe - La boîte paracétamol 10 comprimés (générique)" (in French). Linternaute.com. Retrieved 2018-10-10.

Paroxetine[edit]

A month supply in the United Kingdom costs the NHS about £1.10 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.40.[2]

Society and culture[edit]

A month supply in the United Kingdom costs the NHS about 1.10 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.40.[2]

  1. ^ a b BNF76, page 363
  2. ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Pegaspargase[edit]

In the United States it costs about $US17,800 per 3750 units vial.[1]

  1. ^ "Oncaspar Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 11 October 2019.

Penicillamine[edit]

The wholesale cost in the developing world is about US$0.55 to $1.20 a dose.[1] A month supply in the United Kingdom costs the NHS about 178 £ as of 2019.[2] In the United States the costs of the medication increased from about 500 USD to 24,000 USD per month in 2016.[3]

  1. ^ "Penicillamine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF76, page 1064
  3. ^ Petersen, Melody. "How 4 drug companies rapidly raised prices on life-saving drugs". latimes.com. Retrieved 27 March 2019.

Pentavalent vaccine[edit]

Society and culture[edit]

In November 2010, the public-private consortium GAVI announced that the cost of the pentavalent vaccine for emerging-market countries had dropped below $3.00 USD per dose.[1] In contrast, a typical wholesale cost of a DTPw-HepB-Hib pentavalent vaccine was about $15.40 USD in 2014.[2]

  1. ^ "Price of life-saving vaccine expected to drop significantly in 2011". GAVI. 26 November 2010. Retrieved 3 July 2018.
  2. ^ "Vaccine, Pentavalent". International Drug Price Indicator Guide. Retrieved 6 December 2015.

Peritoneal dialysis[edit]

The cost of dialysis solution in the developing world is about US$6.77–7.30 per two-liter bag or about $12,000 per year.[1][2] In the United States peritoneal dialysis costs the government about $53,400 per person per year.[3]

  1. ^ "Dialysis Sol. Peritoneal W/ Dextrose". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ Ronco, Claudio; Crepaldi, Carlo; Cruz, Dinna N. (2009). Peritoneal Dialysis: From Basic Concepts to Clinical Excellence. Karger Medical and Scientific Publishers. p. 244. ISBN 9783805592024. Archived from the original on 2017-01-13.
  3. ^ Barkoudah, Ebrahim (2016). "Dialysis Initiation During the Hospital Stay". Volume 5, Issue 4, An Issue of Hospital Medicine Clinics. Elsevier Health Sciences. ISBN 9780323463164.

Permethrin[edit]

The wholesale cost in the developing world is about US$0.02 to US$0.06 per gram.[1] In the United States, a course of treatment costs US$25 to US$50, and it is available over the counter.[2]

  1. ^ "Permethrin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 182

Pertussis vaccine[edit]

A version that also includes tetanus, diphtheria, polio, and Hib vaccine is available wholesale in the developing world at a cost of 15.41 USD per dose as of 2014.[1]

  1. ^ "Vaccine, Pentavalent". International Drug Price Indicator Guide. Retrieved 8 December 2015.

Phenoxymethylpenicillin[edit]

The wholesale cost in the developing world is about US$0.05–0.96 per day.[1] In the United States a course of treatment costs less than $25.[2]

  1. ^ "Penicillin, Phenoxymethyl". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 95

Phentermine[edit]

The wholesale cost of a month supply in the United States is about US$2.55.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Phenytoin[edit]

Phenytoin is available as a generic medication and usually not too expensive.[1] The wholesale cost in the developing world is between US$0.003 and US$0.15 per dose.[2] A month of treatment is about US$30 in the United States.[3]

Cost[edit]

Phenytoin is available as a generic medication and usually not too expensive.[1] Wholesale it costs between US$0.003 and US$0.15 per dose.[2] A month of treatment is about US$30 in the United States.[3] After Pfizer's sale of the UK marketing licence to Flynn Pharma, the price of a 28-pack of 25 mg phenytoin sodium capsules marked Epanutin rose from 66p (about $0.88) to £15.74 (about $25.06). Capsules of other strengths also went up in price by the same factor—2384%,[4] costing the UK's National Health Service an extra £43 million (about $68.44 million) a year.[5] The companies were referred to the Competition and Markets Authority who found that they had exploited their dominant position in the market to charge "excessive and unfair" prices.[6] The Competition and Markets Authority (CMA) imposed a record £84.2 million fine on the manufacturer Pfizer, and a £5.2 million fine on the distributor Flynn Pharma and ordered the companies to reduce their prices.[7]

  1. ^ a b TarasonPP2013, page 294
  2. ^ a b "Phenytoin". International Drug Price Indicator Guide. Retrieved 23 August 2015.
  3. ^ a b "Phenytoin". The American Society of Health-System Pharmacists. Retrieved Aug 22, 2015.
  4. ^ "Pharma firm hikes cost of epilepsy drug 24 times", Stephen Adams, Medical Correspondent, Daily Telegraph, London, 12 October 2012 Archived 9 June 2014 at the Wayback Machine. Accessed 13 May 2014.
  5. ^ "Price of anti-epilepsy drug rockets", Mark Gould, Pulse, London, 21 November 2012 Archived 28 November 2012 at the Wayback Machine. Accessed 13 May 2014.
  6. ^ White, Michael (12 August 2015). "Pharma market abuse isn't picked up fast enough". Health Service Journal. Retrieved 6 October 2015.
  7. ^ "CMA fines Pfizer and Flynn £90 million for drug price hike to NHS" (Press release). www.gov.uk. Retrieved 2016-12-07.

Phytomenadione[edit]

The wholesale cost in the developing world is about 0.11 to 1.27 USD for a 10 mg vial.[1] In the United States a course of treatment costs less than 25 USD.[2]

  1. ^ "Vitamin K1". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 229

Pilocarpine[edit]

The wholesale cost in the developing world is about US$1.61–4.88 per 10 ml bottle.[1] In the United States a month of the drops costs less than $25 as of 2015.[2] It is one of the lowest cost medications for glaucoma.[3]

Cost[edit]

The wholesale cost in the developing world is about US$1.61–4.88 per 10 ml bottle.[1] In the United States a month of the drops costs less than $25.[4] It is one of the lowest cost medications for glaucoma.[3]

  1. ^ a b "Pilocarpine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, pages 254, 412
  3. ^ a b Schwab, Larry (2007). Eye Care in Developing Nations. CRC Press. p. 110. ISBN 9781840765229.
  4. ^ TarasconPP2015, page XX

Pioglitazone[edit]

A month supply in the United Kingdom costs the NHS less than £1 as of 2019.[1] In the United States the wholesale cost of this amount is about 3.20 USD.[2]

  1. ^ BNF76, page 694
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Piperacillin/tazobactam[edit]

The wholesale cost in the developing world, as of 2015, is about US$11 per day.[1] In the United Kingdom, as of 2015, this amount costs the NHS about 38.70 pounds per day.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 10 December 2017.
  2. ^ BNF69, page 373

Plazomicin[edit]

The price of 10 days of treatment in the United States costs about US$6,600.[1]

  1. ^ "Zemdri Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 10 October 2019.

Pneumococcal vaccine[edit]

The wholesale cost in the developing world is about US$17 per dose as of 2014.[1] In the United States it is between US$25 and US$100.[2]

  1. ^ "Vaccine, Pneumococcal". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 316

Polio vaccine[edit]

The wholesale cost in the developing world is about US$0.25 per dose for the oral form as of 2014.[1] In the United States, it costs between $25 and $50 for the inactivated form.[2]

Cost[edit]

The wholesale cost is about US$0.25 per dose for the oral form as of 2014.[1] The Global Alliance for Vaccines and Immunization supplies the inactivated vaccine to developing countries for as little as €0.75 (about US$0.89) per dose in 10-dose vials.[3] In the United States, the inactivated form costs between $25 and $50.[2]

  1. ^ a b "Vaccine, Polio". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ a b TarasonPP2015, page 316
  3. ^ "Availability and price of inactivated polio vaccine". The Global Polio Eradication Initiative.

Polymyxin B[edit]

In the United States it costs about US$17 per day.[1]

  1. ^ "Polymyxin b Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 11 November 2019. Typical dose is about 20,000 units per kg * 70 = 1.4 million. So three vials per day.

Polystyrene sulfonate[edit]

A single dose in the United States costs about $US13.50 while 30 doses cost about $US64.00 as of 2019.[1]

  1. ^ "Sodium polystyrene sulfonate Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 25 October 2019.

Potassium chloride (medical use)[edit]

The wholesale cost in the developing world is about 0.44 USD per 10 ml of 10% solution.[1] In the United Kingdom 10 ml of 15% solution costs the NHS about 0.48 pounds.[2]

  1. ^ "Potassium Chloride". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 680, 684

Potassium permanganate[edit]

The wholesale cost in the developing world is about US$0.01 per gram of powder.[1]

  1. ^ "Potassium Permanganate". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Potassium permanganate (medical use)[edit]

The wholesale cost in the developing world is about 0.01 USD per g.[1] In the United Kingdom this amount costs the NHS about £1.33.[2]

  1. ^ "Potassium Permanganate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 840

Povidone-iodine[edit]

The wholesale cost in the developing world is about US$3.30 to US$11.40 per liter of 10% solution.[1] This amount in the United Kingdom cost the NHS about £10.86.[2]

  1. ^ "Povidone iodine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 840

Pramipexole[edit]

A month supply in the United Kingdom costs the NHS about £8.40 as of 2019.[1] In the United States the wholesale cost of this amount is about 5 USD.[2]

  1. ^ BNF76, pages 417–418
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Pravastatin[edit]

In the United States the wholesale cost per dose is less than 0.20 USD as of 2018.[1] In the United Kingdom it costs the NHS about a pound per dose.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 202

Praziquantel[edit]

The wholesale cost in the developing world is about US$0.4–18.15 per day.[1] In the United States a typical course of treatment costs $100–200.[2]

  1. ^ "Praziquantel". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 54

Prazosin[edit]

A month supply in the United Kingdom costs about £3.50 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$20.[2]

  1. ^ BNF76, page 766
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Prednisone[edit]

In the United States, the wholesale cost per dose was less than US$0.30 in 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Pregabalin[edit]

In the US the wholesale costs is about US$11 per month as of October 2019.[1] While in the United Kingdom a similar dose costs the NHS about £6 as of 2018.[2]

Cost[edit]

In the United States as of July 2019 the cost for generic pregabalin is US$0.17-0.22 per 150 mg capsule.[3] Pfizer's main patent for Lyrica, for seizure disorders, in the UK expired in 2013. In November 2018 the Supreme Court of the United Kingdom ruled that Pfizer's second patent on the drug, for treatment of pain, was invalid because there was a lack of evidence for the conditions it covered – central and peripheral neuropathic pain. From October 2015 GPs were forced to change people from generic pregabalin to branded until the second patent ran out in July 2017. This cost the NHS £502 million.[4]

  1. ^ "NADAC as of 2019-10-23". Centers for Medicare and Medicaid Services. Retrieved October 27, 2019.
  2. ^ BNF76, page 323
  3. ^ "Generic Lyrica launches at 97% discount to brand version".
  4. ^ "Pfizer's failed pregabalin patent appeal means NHS could reclaim £502m". Pulse. November 14, 2018. Retrieved November 15, 2018.

Primaquine[edit]

The wholesale cost in the developing world is US$0.04–0.11 per day.[1]

  1. ^ "Primaquine". International Drug Price Indicator Guide. Retrieved 3 December 2016.

Primidone[edit]

A month supply in the United Kingdom costs the NHS about 68.40 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$13.20.[2]

  1. ^ BNF76, page 332
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Procaine benzylpenicillin[edit]

The wholesale cost in the developing world is about US$0.09–0.18 per day.[1] In the United States a course of treatment costs $100–200.[2]

  1. ^ "Penicillin, Procaine Benzyl". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 95

Prochlorperazine[edit]

A dose in the United Kingdom costs the NHS about £0.04 as of 2019.[1] In the United States the wholesale cost of this amount is about US$0.24.[2]

  1. ^ BNF76, pages 385–386
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Proguanil[edit]

The wholesale cost in the developing world is about US$0.10–0.50 per day.[1]

  1. ^ "Proguanil". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Promethazine[edit]

The wholesale cost of the by mouth formulation is less than US$0.20 per dose as of 2018.[1] In the United Kingdom this dose costs less than £0.25.[2]

  1. ^ "NADAC as of 2018-10-24". Centers for Medicare and Medicaid Services. Retrieved 24 October 2018.
  2. ^ BNF74, page 276

Propofol[edit]

The wholesale price in the developing world is between 0.61 and 8.50 USD per vial.[1]

  1. ^ "Propofol". International Drug Price Indicator Guide. Retrieved 23 January 2016.

Propranolol[edit]

The wholesale cost in the developing world is between US$0.24 and US$2.16 per month as of 2014.[1] In the United States it costs about $15 per month at a typical dose.[2]

  1. ^ "Propranolol". International Drug Price Indicator Guide. Retrieved 7 October 2019.
  2. ^ "Propranolol hydrochloride". Monograph. The American Society of Health-System Pharmacists. Retrieved 1 January 2015.

Propylthiouracil[edit]

The wholesale cost in the developing world is about 3.62 USD a month.[1] In the United Kingdom a month costs the NHS about 52.51 pounds.[2] In the United States the wholesale price is 38.34 USD per month.[3]

  1. ^ "Propylthiouracil". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 493
  3. ^ "NADAC as of 2016-12-21 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 26 December 2016.

Protamine sulfate[edit]

The wholesale cost in the developing world is about US$2.82–12.20 per vial.[1]

  1. ^ "Protamine Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Pyrazinamide[edit]

The wholesale cost in the developing world is about US$2.76 per month.[1] In the United States, it costs about US$100 to US$200 per month.[2]

  1. ^ "Pyrazinamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 49

Pyridostigmine[edit]

The wholesale cost in the developing world is about US$7.17–65.93 a month.[1] In the United States it costs about US$25–50 per month.[2]

  1. ^ "Pyridostigmine Bromide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 339

Pyridoxine[edit]

The wholesale cost in the developing world is about US$0.59–3.54 per month.[1]

  1. ^ "Vitamin B6". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Quetiapine[edit]

In the United States, the wholesale cost is about US$12 per month as of 2017.[1] In the United Kingdom, a month's supply costs the NHS about £60 as of 2017.[2]

Cost[edit]

In the United States as of 2015, the branded extended-release 400 mg pills cost between US$9.68 and US$23.16 each.[3] In 2017, the short-acting version had a wholesale cost of about US$12 per month.[1] In the United Kingdom, a month's supply, as of 2017, costs the NHS approximately £107.45.[2] This is following an increase of 30 to 70 fold in 2017/2018.[4]

  1. ^ a b "NADAC as of 2017-03-22". Centers for Medicare and Medicaid Services. Retrieved 26 March 2017.
  2. ^ a b BNF74, page 383
  3. ^ Langreth R (June 29, 2016). "Decoding Big Pharma's Secret Drug Pricing Practices". Bloomberg. Retrieved 15 July 2016.
  4. ^ "NHS hit by seven-fold increase in bill for certain drugs". Health Service Journal. 8 June 2018. Retrieved 29 August 2018.

Quinapril[edit]

In the United States the wholesale cost of this amount is about US$3.50.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Quinine[edit]

The wholesale price in the developing world is about US$1.70 to $3.40 per course of treatment.[1] In the United States a course of treatment is more than $200.[2]

  1. ^ "Quinine Sulfate". International Drug Price Indicator Guide. Retrieved 12 January 2016.
  2. ^ TarasconPP2015, page 47

Rabeprazole[edit]

A month supply in the United Kingdom costs the NHS about £1 as of 2019.[1] In the United States the wholesale cost of this amount is about 11 USD.[2]

  1. ^ BNF76, page 82
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Rabies vaccine[edit]

The wholesale cost in the developing world is between 44 and 78 USD for a course of treatment as of 2014.[1] In the United States a course of rabies vaccine is more than 750 USD.[2]

  1. ^ "Vaccine, Rabies". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ Shlim, David (June 24, 2019). "Perspectives: Intradermal Rabies Preexposure Immunization". Centers for Disease Control and Prevention (CDC). Retrieved 26 December 2019.

Raloxifene[edit]

In the United States the wholesale cost of this amount is about 16 USD.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Raltegravir[edit]

The wholesale cost in the developing world is about 50 USD per month.[1] In the United Kingdom it costs the NHS about 472.00 pounds per month.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ BNF69, page 429

Ramipril[edit]

A month supply in the United Kingdom costs the NHS less than £1 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$2.[2]

  1. ^ BNF76, pages 172–173
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ranitidine[edit]

The 2015 wholesale price in the developing world was about US$0.01–0.05 per pill.[1] In the United States it is about $0.05 per dose.[2]

  1. ^ "Ranitidine". International Drug Price Indicator Guide. Retrieved 1 December 2015.
  2. ^ "Ranitidine Hydrochloride Monograph". The American Society of Health-System Pharmacists. Retrieved 1 December 2015.

Ranolazine[edit]

A month supply in the United Kingdom costs the NHS about 50 £ as of 2019.[1] In the United States the wholesale cost of this amount is about 343 USD.[2]

  1. ^ BNF76, page 210
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Regular insulin[edit]

The wholesale cost in the developing world is about US$2.39–10.61 per 1,000 iu of regular insulin.[1] In the United Kingdom 1,000 iu costs the NHS £7.48, while in the United States this amount is about $134.00.[2][3]

  1. ^ "Insulin, Neutral Soluble". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 464-472
  3. ^ "NADAC as of 2016-12-07 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 17 January 2017.

Retinol[edit]

The wholesale cost in the developing world is about US$0.02–0.30 per 50,000 units.[1] In the United States it is not very expensive.[2]

  1. ^ "Vitamin A". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 230

Rifabutin[edit]

The wholesale cost in the developing world is about US$30 a month.[1] In the United States a month of treatment is more than $200.[2]

  1. ^ "Rifabutin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 50

Rifampicin[edit]

The wholesale cost in the developing world is about US$3.90 a month.[1] In the United States a month of treatment is about $120.[2][3]

  1. ^ "Rifampicin". International Drug Price Indicator Guide. Retrieved 24 August 2015.
  2. ^ "Rifampin". The American Society of Health-System Pharmacists. Retrieved Aug 1, 2015.
  3. ^ TarasconPP2014, page 39

Rifampicin/isoniazid/pyrazinamide[edit]

The wholesale cost in the developing world is about 3.93 USD a month.[1] In the United Kingdom a month of treatment costs the NHS about 39.51 pounds.[2]

  1. ^ "Rifampicin + Isoniazid + Pyrazinamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 403

Ringer's lactate solution[edit]

The wholesale cost in the developing world is about US$0.60 to US$2.30 per liter.[1]

  1. ^ "Sodium Lactate Compound". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Risperidone[edit]

The wholesale price in the developing world is between US$0.01 and US$0.60 per day as of 2014.[1] The cost for a typical month of medication in the United States is between US$100-200 as of 2015.[2]

  1. ^ "Risperidone". International Drug Price Indicator Guide. Retrieved 2 December 2015.
  2. ^ TarasconPP2015, page XX

Ritonavir[edit]

Globally the wholesale cost in the developing world is between US$0.07 and $2.20 per day.[1] In the United States it costs about $9.20–55 per day depending on the dose.[2]

History[edit]

In 2003, Abbott (now AbbVie, Inc.) raised the price of a Norvir course from USD $1.71 per day to $8.57 per day, leading to claims of price gouging by patients' groups and some members of Congress.

  1. ^ "Ritonavir". International Drug Price Indicator Guide. Retrieved 23 October 2015.
  2. ^ "Ritonavir". The American Society of Health-System Pharmacists. Retrieved Oct 23, 2015.

Rituximab[edit]

The wholesale price in the developing world as of 2014 was US$148–496 per 100 mg.[1] In the United Kingdom, the NHS paid approximately £182 per 100 mg in 2015.[2] In the United States, the average price paid was approximately $705 per 100 mg in 2014.[3] The typical treatment for rheumatoid arthritis (1,000 mg IV dose, 2 weeks apart) in the United States would have been $14,100 a month in 2014.[3]

  1. ^ "Rituximab". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ BNF69, page 638
  3. ^ a b "Drugs for Rheumatoid Arthritis". The Medical Letter. 56 (1458): 127–32. 22 December 2014.

Rivaroxaban[edit]

A month supply in the United Kingdom costs the NHS about £50 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$430.[2]

Society and culture[edit]

Using rivaroxaban rather than warfarin costs 70 times more, according to Express Scripts Holding Co, the largest U.S. pharmacy benefits manager.[3]

  1. ^ BNF76, pages 127–128
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Bill Berkrot (December 23, 2015). "New blood thinner 'antidote' to help doctors move past warfarin". Reuters.

Rizatriptan[edit]

A dose in the United Kingdom costs the NHS about 3.10 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$0.73.[2]

  1. ^ BNF76, page 473
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Ropinirole[edit]

A month supply in the United Kingdom costs the NHS about 34 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$7.90.[2]

  1. ^ BNF76, pages 419–420
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Rosuvastatin[edit]

In the United States, the wholesale cost per dose is less than US$0.15 as of 2018.[1] In the United Kingdom, it costs the NHS about £0.65 per dose as of 2018.[2]

Marketing[edit]

Annual cost to the UK National Health Service (NHS) in 2018 for 5-40mg rosuvastatin daily was £24-40, compared to £10-20 for 20-80mg simvastatin.[3]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services (CMS). Retrieved 22 December 2018.
  2. ^ BNF76, page 203
  3. ^ "COST COMPARISON CHARTS" (PDF). REGIONAL DRUG AND THERAPEUTICS CENTRE (NEWCASTLE). August 2018.

Rotavirus vaccine[edit]

The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.[1] In the United States it is more than US$200.[2]

<<<Extensive discussion of cost and cost-effectiveness>>>

  1. ^ "Vaccine, Rotavirus". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 317

Rubella vaccine[edit]

The wholesale cost of the MMR vaccine in the developing world is 0.24 USD per dose as of 2014.[1] In the United States it costs between 50 and 100 USD.[2]

  1. ^ "Vaccine, Measles-Mumps-rubella". International Drug Price Indicator Guide. Retrieved 8 December 2015.
  2. ^ TarasconPP2015, page 315

Salbutamol[edit]

The wholesale cost in the developing world of an inhaler which contains 200 doses is between US$1.12 and US$2.64 as of 2014.[1] In the United States, it is between US$25 and US$50 for a typical month's supply.[2]

Cost[edit]

International wholesale price of 200 doses of salbutamol[1]

The wholesale cost of a 200-dose inhaler is between US$1.12 and US$2.64 in the developing world as of 2014[1] and £1.50 in the United Kingdom as of 2015.[3] In the United States, a typical month's supply is between $25 and $50.[4]

  1. ^ a b c "Salbutamol". International Drug Price Indicator Guide. Retrieved 5 December 2015.
  2. ^ TarasconPP2015, page 448
  3. ^ BNF69, page 190
  4. ^ TarasconPP2015, page XX

Saline (medicine)[edit]

The wholesale cost in the developing world is about US$0.60–4.20 per liter of normal saline.[1]

  1. ^ "Sodium Chloride in Water". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Saquinavir[edit]

As of 2015 it is not available as a generic medication in the United States and is expensive.[1] The wholesale cost in the developing world is about 4.50 USD per day.[2]

Cost[edit]

As of 2015 it is not available as a generic medication and is expensive.[3] The wholesale cost is about 4.50 USD per day.[2]

  1. ^ TarasconPP2015, page 72
  2. ^ a b "Saquinavir". International Drug Price Indicator Guide. Retrieved 6 September 2015.
  3. ^ TarasconPP2015, page XX

Senna glycoside[edit]

The wholesale cost in the developing world is about 0.01 USD per pill.[1] Sennosides come from the group of plants Senna.[2]

  1. ^ "Senna". International Drug Price Indicator Guide. Retrieved 11 August 2015.
  2. ^ Navti, Phyllis (2010). Pharmacology for pharmacy and the health sciences : a patient-centred approach. Oxford: Oxford University Press. p. 337. ISBN 9780199559824.

Sertraline[edit]

In the United States, the wholesale cost is about US$1.50 per month as of 2018.[1]

  1. ^ "NADAC as of 2018-01-03". Centers for Medicare and Medicaid Services. Retrieved 7 January 2018.

Sildenafil[edit]

As of 2018 in the United States the wholesale cost is less than US$1 per dose.[1]

  1. ^ "NADAC as of 2018-11-21". Centers for Medicare and Medicaid Services. Retrieved 24 November 2018.

Silver sulfadiazine[edit]

In the developing world the wholesale cost is between 0.004 and 0.072 USD per gram.[1] In the United States, a course of treatment is generally less than 25 USD.[2][3]

  1. ^ "Silver Sulfadiazine". International Drug Price Indicator Guide. Retrieved 30 August 2016.
  2. ^ "NADAC as of 2018-10-03". Centers for Medicare and Medicaid Services. Retrieved 7 October 2018.
  3. ^ "Silver Sulfadiazine Prices and Silver Sulfadiazine Coupons - GoodRx". October 7, 2018.

Simvastatin[edit]

The wholesale cost in the developing world is US$0.01 to 0.12 per day as of 2014.[1] In the United States, it costs between US$0.50 and 1.00 per day.[2]

Society and culture[edit]

In the UK in 2008, the typical per-patient cost to the NHS of simvastatin was about £1.50 per month.[3] (40 mg/day costs UK NHS £1.37/month in 2012[4])

  1. ^ "Simvastatin". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ "Simvastatin". The American Society of Health-System Pharmacists. Retrieved 8 January 2015.
  3. ^ "NHS overspends on statins". Jan 2008.
  4. ^ "Simvastatin 40mg tablets".

Sitagliptin[edit]

A month's supply in the United Kingdom costs the NHS about £33.26 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$405.00.[2]

  1. ^ BNF76, page 681
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Sitagliptin/metformin[edit]

A month supply in the United Kingdom costs the NHS about 33.26 £ as of 2019.[1] In the United States the wholesale cost of this amount is about 433 USD.[2]

Price[edit]

A month supply in the United Kingdom costs the NHS about 33.26 £ as of 2019.[1] In the United States the wholesale cost of this amount is about 433 USD.[2] In Denmark 100 tablets (each 1,000 mg) cost over the counter in a pharmacy DKK 62.60 = US$ 9.40 = £7.50, thus a month supply in Denmark costs DKK 37.50 = US$ 5.70 = £ 4.50. The pharmacy buys wholesale at DKK 33.83 = US$ 5.11 = £4.10.[3]

  1. ^ a b BNF76, page 682
  2. ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "Medicinpriser". Medicinpriser (in Danish). Retrieved 17 June 2019.

Sodium stibogluconate[edit]

The wholesale price in the developing world is 9.66 USD per vial.[1] This gives the cost for a course of treatment at between 12 and 56 USD.[2]

  1. ^ "Sodium Stibogluconate". International Drug Price Indicator Guide. Retrieved 6 December 2016.
  2. ^ Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (PDF). World Health Organization. March 2010. p. 55,186. ISBN 9789241209496. Archived (PDF) from the original on 2016-06-08.

Sodium zirconium cyclosilicate[edit]

In the United States it costs about $US24 per dose.[1] In the United Kingdom as of 2019 it costs the NHS about £7.12 per dose.[2]

  1. ^ "Lokelma Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 11 October 2019.
  2. ^ "SODIUM ZIRCONIUM CYCLOSILICATE | Medicinal forms | BNF content published by NICE". webcache.googleusercontent.com. NICE. Retrieved 11 October 2019.

Solifenacin[edit]

A month's supply in the United Kingdom costs the NHS about £27.62 as of 2019.[1] In the United States the wholesale cost of this amount is about 370 USD.[2]

Cost[edit]

A 2006 cost-effectiveness study found that 5 mg solifenacin had the lowest cost and highest effectiveness among anticholinergic drugs used to treat overactive bladder in the United States, with an average medical cost per successfully treated patient of $6863 per year.[3] By 2019, with the introduction of generics, the retail cost of a month's supply was down to $20 in the US.

  1. ^ BNF76, page 761
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ Ko Y, Malone DC, Armstrong EP (Dec 2006). "Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder". Pharmacotherapy. 26 (12): 1694–702. doi:10.1592/phco.26.12.1694. PMID 17125433.

Sotalol[edit]

A month supply in the United Kingdom costs the NHS about 5 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$11.[2]

  1. ^ BNF76, page 108
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Spectinomycin[edit]

The wholesale cost in the developing world is about US$5 per dose.[1]

  1. ^ "Spectinomycin". International Drug Price Indicator Guide. Retrieved 7 September 2015.

Spironolactone[edit]

The wholesale cost in the developing world as of 2014 is between US$0.02 and US$0.12 per day.[1] In the United States it costs about US$0.50 per day.[2]

  1. ^ "Spironolactone". International Drug Price Indicator Guide. Retrieved 29 November 2015.
  2. ^ "Spironolactone". The American Society of Health-System Pharmacists. Retrieved Oct 24, 2015.

Stavudine[edit]

The wholesale cost in the developing world is US$1.86–5.40 per month.[1]

Adverse events[edit]

On Monday 30 November 2009, the World Health Organization stated that "[The WHO] recommends that countries phase out the use of Stavudine, or d4T, because of its long-term, irreversible side-effects. Stavudine is still widely used in first-line therapy in developing countries due to its low cost and widespread availability. Zidovudine (AZT) or tenofovir (TDF) are recommended as less toxic and equally effective alternatives."[2]

  1. ^ "Stavudine". International Drug Price Indicator Guide. Retrieved 30 November 2016.
  2. ^ "New HIV recommendations to improve health, reduce infections and save lives". World Health Organization. November 30, 2009.

Streptokinase[edit]

The wholesale cost is between 30.00 and US$138.00 per dose as of 2014.[1]

  1. ^ "Streptokinase". International Drug Price Indicator Guide. Retrieved 28 November 2015.

Streptomycin[edit]

The wholesale cost in the developing world is between US$0.38 and $4.39 per day.[1] In the United States, a course of treatment costs more than $200.[2]

  1. ^ "Streptomycin Sulfate". International Drug Price Indicator Guide. Retrieved December 8, 2016.
  2. ^ TarasconPP2015, page 36

Sucralfate[edit]

In the United States the wholesale cost is about US$0.22 per dose.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Sulfadiazine[edit]

The wholesale cost in the developing world is about US$2.70 to 7.32 a month.[1] In the United States, treatment costs more than $200 per month.[2]

  1. ^ "Sulfadiazine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 104

Sulfadoxine/pyrimethamine[edit]

The wholesale cost in the developing world is about US$0.08–0.36 per day.[1]

  1. ^ "Sulfadoxine + Pyrimethamine". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Sulfasalazine[edit]

The wholesale cost in the developing world is about US$9–33 a month as of 2014.[1] In the United States it costs $25–50 per month for a typical dose.[2]

Cost[edit]

The wholesale cost in the developing world is about US$9–33 a month as of 2014.[1] In the United States the average wholesale cost is about $25–50 per month for a typical dose.[3]

  1. ^ a b "Sulfasalazine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 464
  3. ^ TarasconPP2015, page XX

Sumatriptan[edit]

In the United Kingdom it costs the NHS about £1 per dose as of 2019.[1] In the United States the wholesale cost of this amount is about US$0.60.[2]

  1. ^ BNF76, page 474
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Sumatriptan/naproxen sodium[edit]

In the United States the combination costs about 50 USD per dose.[1] By themselves a dose of sumatriptan costs about 0.60 USD while a dose of naproxen is about 0.18 USD.[2]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Suxamethonium chloride[edit]

The wholesale cost in the developing world is about US$0.45 to US$1.31 a dose.[1]

  1. ^ "Suxamethonium Cl". International Drug Price Indicator Guide. Retrieved 8 December 2016.

Tadalafil[edit]

In the UK it costs the NHS about 0.80 £ per dose as of 2019.[1] In the United States the wholesale cost of this amount is about US$1.91.[2]

Cost[edit]

In the United States, the wholesale cost of tadalafil as of May 2019 is US$1.91 for the 20 mg tabs and US$7.65 for the 2.5 mg tabs.[2] While some health insurance providers cover at least part of the cost (typically limiting the number of doses covered per month), many providers, including those operating under Medicare Part D, do not cover the cost of medications prescribed for erectile dysfunction.[3][4] In the U.K., a generic version of tadalafil became available in November 2017, reducing its price per pill, and will be available on the NHS. Additionally, Tadacip, manufactured in India by Cipla, is considerably less expensive.

  1. ^ BNF76, page 796
  2. ^ a b "NADAC as of 2019-05-15". Centers for Medicare and Medicaid Services. Retrieved 29 May 2019.
  3. ^ Parker-Pope, Tara (August 28, 2009). "The Cost of Treating Erectile Dysfunction". New York Times. Retrieved 20 Dec 2016.
  4. ^ United Health Care (August 16, 2016). "Coverage Summary -- Impotence Treatment" (PDF). United Health Care. Retrieved 20 Dec 2016.

Tafenoquine[edit]

In the United States, as of 2019, a course of treatment costs about US$43.[1] Tafenoquine is related to primaquine.[2]

  1. ^ "Krintafel Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 22 November 2019.
  2. ^ "Tafenoquine Approved for Malaria Prophylaxis and Treatment". Centers for Disease Control and Prevention (CDC). 25 April 2019. Retrieved 22 November 2019.

Tamoxifen[edit]

The wholesale price in the developing world is about US$0.07–0.23 per day.[1] In the United States, it costs about $1 per day.[2]

  1. ^ "Tamoxifen Citrate". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ "Tamoxifen Citrate". The American Society of Health-System Pharmacists. Retrieved 27 Nov 2015.

Tamsulosin[edit]

In the United States, the wholesale cost per dose is less than 0.10 USD as of 2018.[1] In the United Kingdom, it costs the NHS 0.04 pounds per dose as of 2018.[2]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
  2. ^ BNF76, page 767

Telmisartan[edit]

A month supply in the United Kingdom costs the NHS less than £2 as of 2019.[1] In the United States the wholesale cost of this amount is about US$10.[2]

Society and culture[edit]

A month supply in the United Kingdom costs the NHS less than £2 as of 2019.[1] In the United States the National Average Drug Acquisition Cost of this amount is about US$10 as of 2019.[3]

  1. ^ a b BNF76, page 178
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Telmisartan/amlodipine[edit]

In the United States it costs at least US$57 per month as of 2019.[1]

  1. ^ "Amlodipine/telmisartan Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 30 October 2019.

Telmisartan/hydrochlorothiazide[edit]

A month of medication costs the NHS about £17 as of 2018.[1] In the United States it costs about US$65 per month as of 2019.[2]

  1. ^ BNF76, page 178
  2. ^ "Hydrochlorothiazide/telmisartan Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 29 October 2019.

Temazepam[edit]

A month supply in the United Kingdom costs the NHS about £1.40 as of 2019.[1] In the United States, the wholesale cost of this amount is about US$1.76.[2]

  1. ^ BNF76, page 481
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Tenofovir disoproxil[edit]

The wholesale cost in the developing world is between US$3.30 and $29.13 per month.[1] As of 2015 the cost for a typical month of medication in the United States is more than $200.[2]

  1. ^ "Tenofovir Disoproxil Fumerate (Tdf)". International Drug Price Indicator Guide. Retrieved 30 November 2016.
  2. ^ TarasconPP2015, page 66

Terazosin[edit]

A month supply in the United Kingdom costs the NHS less than 2 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.50.[2]

  1. ^ BNF76, page 768
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Terbinafine[edit]

The wholesale cost in the developing world is about 2.20 USD for a 20 g tube.[1] In the United States the price in 1999 was $547 for a 12-week course; this fell to $10 by 2015, after the patent had expired.[2]

  1. ^ "Terbinafine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ Mikailov A, Cohen J, Joyce C, Mostaghimi A (2015). "Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis". JAMA Dermatology. 152 (3): 1–6. doi:10.1001/jamadermatol.2015.4190. PMID 26716567.

Tetanus vaccine[edit]

The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.[1] In the United States a course of tetanus vaccine is between 25 and 50 USD.[2]

  1. ^ "Vaccine, Tetanus Toxoid". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 317

Tetracaine[edit]

The wholesale cost in the developing world is about US$1.34–1.63 per 10 ml bottle.[1] In the United Kingdom the eye drops cost the NHS about 0.49 pounds per dose.[2]

  1. ^ "Tetracaine". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, pages 769, 897

Tetracycline[edit]

The wholesale cost in the developing world is about 0.35 to 1.78 USD for a course of treatment.[1] In the United States a course of treatment typically costs less than 25 USD.[2] Tetracycline was originally made from bacteria of the Streptomyces type.[3]

Price[edit]

According to data from EvaluatePharma and published in the Boston Globe, the price of tetracycline rose from $0.06 per 250-mg pill in 2013 to $4.06 a pill in 2015.[4] The Globe described the "big price hikes of some generic drugs" as a "relatively new phenomenon" which has left most pharmacists "grappling" with large upswings" in the "costs of generics, with 'overnight' price changes sometimes exceeding 1,000%."[4]

  1. ^ "Tetracycline HCL". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 107
  3. ^ "Tetracycline". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.
  4. ^ a b McCluskey, Priyanka Dayal (6 November 2015). "As competition wanes, prices for generics skyrocket". Boston Globe. Retrieved 18 November 2015.

Thalidomide[edit]

In the United Kingdom it costs the NHS about £1,194 per month as of 2018.[1] This amount in the United States costs about US$9,236 as of 2019.[2]

Cost[edit]

In the United Kingdom it costs the NHS about £1,194 per month as of 2018.[1] This amount in the United States costs about US$9,236 as of 2019.[2]

  1. ^ a b BNF76, page 936
  2. ^ a b "Thalomid Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 15 November 2019.

Thiamazole[edit]

A month supply in the United States has a wholesale cost of about US$6.80.[1] It is also available in Europe and Asia.[2]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  2. ^ Jastrzębska, Helena (2015). "Antithyroid drugs". Thyroid Research. 8 (Suppl 1): A12. doi:10.1186/1756-6614-8-S1-A12. PMC 4480840.{{cite journal}}: CS1 maint: unflagged free DOI (link)

Thiamine[edit]

The wholesale cost in the developing world (as of 2016) is about US$2.17 per one gram vial.[1] In the United States a month's supply of a multivitamin containing thiamine is less than US$25.[2]

  1. ^ "Vitamin B1". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 230

Timolol[edit]

The wholesale cost in the developing world is about US$0.86–2.29 per 5 ml bottle.[1] In the United States it costs US$25–50 per month.[2]

  1. ^ "Timolol Maleate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 411

Tioguanine[edit]

The wholesale price in the developing world is about 7.07 USD per 40 mg pill as of 2014.[1] In the United Kingdom this amount costs the NHS about 4.14 pounds.[2]

  1. ^ "Tioguanine". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ BNF69, pages 588, 592

Tiotropium bromide[edit]

In the United States the wholesale cost was about US$13.75 per dose as of 2019.[1] In the United Kingdom a dose costs the NHS about 0.86 pounds as of 2019.[2]

  1. ^ "NADAC as of 2019-01-30". Centers for Medicare and Medicaid Services. Retrieved 31 January 2019.
  2. ^ BNF76, pages 247–248

Tizanidine[edit]

A month supply in the United Kingdom costs the NHS about 3.45 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.20.[2]

  1. ^ BNF76, page 1094
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Tolterodine[edit]

A month supply costs the NHS about GB£2.09 per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$37.16.[2]

  1. ^ BNF76, page 762
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Topiramate[edit]

A month supply in the United Kingdom costs the NHS about £1.40 per month as of 2019.[1] In the United States the wholesale cost of this amount is about 4.00 USD.[2]

  1. ^ BNF76, page 328
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Torasemide[edit]

A month supply in the United Kingdom costs the NHS less than 10 £ as of 2019.[1] In the United States the wholesale cost of this amount is about XXX USD.[2]

  1. ^ BNF76, pages 227–228
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Tramadol[edit]

In the United States, the wholesale cost is less than US$0.05 per dose as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Tranexamic acid[edit]

The wholesale cost in the developing world is about 4.38 to US$4.89 for a course of treatment.[1] In the United States, a course of treatment costs between 100 and US$200.[2]

  1. ^ "Tranexamic Acid". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015

Trastuzumab[edit]

As of 2014, the wholesale price in the developing world is between US$1,800 and US$1,955 per 440 mg vial.[1] In the United Kingdom, a 150 mg vial costs the NHS £407.00.[2]

Costs[edit]

Trastuzumab costs about US$70,000 for a full course of treatment,[3] Trastuzumab brought in $327 million in revenue for Genentech in the fourth quarter of 2007.[citation needed] Australia has negotiated a lower price of A$50,000 per course of treatment.[4] Since October 2006, trastuzumab has been made available for Australian women and men with early-stage breast cancer via the Pharmaceutical Benefits Scheme. This is estimated to cost the country over A$470 million for 4–5 years supply of the drug.[5] Roche has changed the trade name of the drug and has re-introduced an affordable version of the same in the Indian market.[when?] The new drug named Herclon would cost approximately RS75,000 INR (US$1,200) [clarification needed] in the Indian market.[citation needed] On September 16, 2014, Genentech notified hospitals in the United States that, as of October, trastuzumab could only be purchased through their selected specialty drugs distributors not through the usual general line wholesalers. By being forced to purchase through specialty pharmacies, hospitals lost rebates from the big wholesalers and the ability to negotiate cost-minus discounts with their wholesalers.[6]

  1. ^ "Trastuzumab". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ BNF69, page 626
  3. ^ Fleck L (2006). "The costs of caring: Who pays? Who profits? Who panders?". Hastings Cent Rep. 36 (3): 13–7. doi:10.1353/hcr.2006.0040. PMID 16776017.
  4. ^ "Listing of Herceptin on PBS". Australian Government, Dept of Health and Ageing. 2006-10-01. Retrieved 2009-08-06.
  5. ^ Australian Government, Dept of Health and Ageing "Listing of Herceptin on PBS", 2006-10-1. "Pharmaceutical Benefits Scheme (PBS) | Listing of Herceptin on the PBS". Retrieved 2013-10-20.
  6. ^ Saporito, Bill (27 October 2014). "Hospitals Furious at Cancer-Drug Price Hikes". Time. Retrieved 26 October 2015.

Travoprost[edit]

A 2.5 milliliter bottle in the United Kingdom costs the NHS about 7.30 £ as of 2019.[1] In the United States the wholesale cost of this amount is about US$177.[2]

  1. ^ BNF76, page 1152
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Trazodone[edit]

The cost in the United Kingdom for the NHS is about £7.46 per month as of 2019.[1] In the United States, the wholesale cost is about US$4.53 per month as of 2018.[2]

  1. ^ BNF76, page 367
  2. ^ "NADAC as of 2018-01-03". Centers for Medicare and Medicaid Services. Retrieved 7 January 2018.

Triamcinolone[edit]

In the United States the wholesale cost is about US$0.06 per gram for the cream.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Tropicamide[edit]

The wholesale cost in the developing world is about US$4.19–4.55 per 15 ml bottle.[1] In the United States a course of treatment costs less than $25.[2]

  1. ^ "Tropicamide". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 415

Tuberculin[edit]

The wholesale cost in the developing world is about 0.22 USD per dose.[1] In the United States testing costs less than 25 USD.[2]

  1. ^ "Tuberculin". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 323

Typhoid vaccine[edit]

The wholesale cost in the developing world is about US$4.44 per dose as of 2014.[1] In the United States they cost $25–50.[2]

  1. ^ "Vaccine, Typhoid". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 317

Valaciclovir[edit]

A month supply in the United Kingdom costs the NHS about £3 as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.80.[2] In 2016 it was the 168th most prescribed medication in the United States with more than 3 million prescriptions.[3]

History[edit]

A month supply in the United Kingdom costs the NHS about £3 as of 2019.[1] In the United States the wholesale cost of this amount is about US$2.80.[2]

  1. ^ a b BNF76, pages 625–626
  2. ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  3. ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.

Valganciclovir[edit]

The wholesale price in the developing world is between 30.16 and 52.14 USD per day.[1] In the United States as of 2016 the wholesale costs were about 58.54 USD per day.[2]

Price and patent status[edit]

The price of a four-month course of valganciclovir from Roche is about US$8,500 in high-income countries, $6,000 in India. However, the valganciclovir patent was rejected by the Indian Patent Office[3]

  1. ^ "Valganciclovir". International Drug Price Indicator Guide. Retrieved 29 November 2016.
  2. ^ "NADAC". Medicaid.gov. Retrieved 29 November 2016.
  3. ^ Valganciclovir rejected by the Indian Patent Office

Valproate[edit]

The wholesale cost in the developing world is about US$0.40 per day as of 2015.[1] In the United States, the wholesale cost is roughly US$1.30 per day as of 2019.[2]

Cost[edit]

The wholesale cost in the developing world is about US$0.40 per defined daily dose as of 2015.[1] In the United States, the National Average Drug Acquisition Cost is roughly US$1.30 per day for the short acting formulation as of 2019.[2] The price to a consumer in the United States for this amount is about $US2.30 per day as of 2019.[3] The long acting formulations are more expensive.[2] In the European Union, end-user costs are less than 0.60 EUR for an average daily dose in Germany.[4][citation needed]

  1. ^ a b "Sodium Valproate | International Medical Products Price Guide".
  2. ^ a b c "NADAC as of 2019-11-27 | Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Retrieved 25 November 2019.
  3. ^ "Valproic acid Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 25 November 2019.
  4. ^ Regular pharmacy price, including all taxes, et cetera: less than 34,43 EUR for 200 controlled release pills with 500mg each; date: 2016-11-30

Valsartan[edit]

A month supply in the United Kingdom costs the NHS about 5 £ per month as of 2019.[1] In the United States the wholesale cost of this amount is about US$7.50.[2]

  1. ^ BNF76, page 179
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Valsartan/hydrochlorothiazide[edit]

A month supply in the United Kingdom costs the NHS about 1.85 as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.40.[2]

  1. ^ BNF76, page 179
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Vancomycin[edit]

The wholesale cost in the developing world of an intravenous dose is about US$1.70 to 6.00.[1] In the United States, the capsules are more expensive than the intravenous solution.[2]

Cost[edit]

The wholesale cost of an intravenous dose is about US$1.70 to 6.00.[1] In the United States, the wholesale cost of the pills are about US$300 for a course of treatment as of 2018.[3]

  1. ^ a b "Vancomycin". International Drug Price Indicator Guide. Retrieved 5 September 2015.
  2. ^ "Vancocin". The American Society of Health-System Pharmacists. Retrieved Sep 4, 2015.
  3. ^ "NADAC as of 2018-01-17". Centers for Medicare and Medicaid Services. Retrieved 20 January 2018.

Venlafaxine[edit]

In the United States the wholesale cost per dose is less than US$0.20 as of 2018.[1]

  1. ^ "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.

Verapamil[edit]

The wholesale cost in the developing world is about US$1.71–2.70 per month.[1] In the United States a month of treatment costs $25–50.[2] Long acting formulations exist.[3]

  1. ^ "Verapamil HCL". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 156
  3. ^ WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 267. ISBN 9789241547659. Retrieved 8 December 2016.

Vilazodone[edit]

In the United States the wholesale cost for a month of medication is about 261 USD.[1]

  1. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Vinblastine[edit]

As of 2014 the wholesale cost in the developing world is about US$7.70 and US$31.70 per dose.[1] In the United Kingdom it costs £13.09 per 10 mg vial.[2]

  1. ^ "Vinblastine". Retrieved 28 November 2015.
  2. ^ BNF69, page 593

Vincristine[edit]

The wholesale cost in the developing world is between US$1.80 and US$42.60 per dose.[1]

  1. ^ "Vincristine". International Drug Price Indicator Guide. Retrieved 28 November 2015.

Vinorelbine[edit]

The wholesale price in the developing world as of 2014 is between 18.10 and 42.82 USD per 50 mg vial.[1] This amount in the United Kingdom costs the NHS about 139.00 pounds.[2]

  1. ^ "Vinorelbine". International Drug Price Indicator Guide. Retrieved 28 November 2015.
  2. ^ BNF69, page 594

Vitamin C[edit]

Industrial production[edit]

In 2017, China produced about 95% of the world supply of ascorbic acid (vitamin C),[1] which is China's most exported vitamin, having total revenue of US$880 million in 2017.[2] Due to pressure on Chinese industry to discontinue burning coal normally used for vitamin C manufacturing, the price of vitamin C rose three-fold in 2016 alone to US$12 per kg.[1]

  1. ^ a b Jeff Gelski (6 November 2017). "Vitamin C prices triple in a year's time". FoodBusiness News. Retrieved 15 August 2019.
  2. ^ Tingmin Koe (28 August 2018). "'China-free' vitamin C: Industry defends standards against 'marketing claims'". NutraIngredients-Asia.com, William Reed Business Media, Ltd. Retrieved 15 August 2019.

Voriconazole[edit]

The wholesale cost in the United States, as of 2019, is about 9 USD per day.[1]

  1. ^ "NADAC as of 2019-08-21". Centers for Medicare and Medicaid Services. Retrieved 2019-09-23.

Vortioxetine[edit]

A month supply in the United Kingdom costs the NHS about £27.72 as of 2019.[1] In the United States the wholesale cost of this amount is about 368.40 USD.[2]

  1. ^ BNF76, page 376
  2. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.

Warfarin[edit]

The wholesale cost in the developing world is about US$1.12 to 7.20 for a typical month of treatment.[1] In the United States it usually costs less than $25 a month.[2]

  1. ^ "Warfarin Sodium". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ TarasconPP2015, page 289

Water for injection[edit]

The wholesale cost in the developing world is about US$0.03–0.15 per 10 ml vial.[1] In the United Kingdom this amount cost the NHS 0.25 to 1.40 pounds.[2]

  1. ^ "Water for Injection". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 685

Xylometazoline[edit]

The wholesale cost in the developing world is about 0.75 USD for a 10 ml bottle.[1] In the United Kingdom that dose costs the NHS about 2.10 pounds.[2]

  1. ^ "Xylometazoline". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 786

Yellow fever vaccine[edit]

The wholesale price in the developing world is between US$4.30 and US$21.30 per dose as of 2014.[1] In the United States it costs between US$50 and US$100.[2]

  1. ^ "Vaccine, Yellow Fever". International Drug Price Indicator Guide. Retrieved 6 December 2015.
  2. ^ TarasconPP2015, page 318

Zidovudine[edit]

The wholesale cost in the developing world is US$5.10 to $25.60 per month.[1] As of 2015, the cost for a typical month of medication in the United States was more than $200.[2]

  1. ^ "Zidovudine". International Drug Price Indicator Guide. Retrieved November 28, 2016.
  2. ^ TarasconPP2015, page 67

Zinc sulfate (medical use)[edit]

The wholesale cost in the developing world is about US$0.01–18 per day.[1] In the United Kingdom ten days of treatment costs the NHS about 4.32 pounds.[2]

  1. ^ "Zinc Sulfate". International Drug Price Indicator Guide. Retrieved 8 December 2016.
  2. ^ BNF69, page 700

Zoledronic acid[edit]

The wholesale cost in the developing world is between 5.73 USD and 26.80 USD per vial.[1] In the United Kingdom, as of 2015, a dose costs the NHS about 220 pounds.[2]

  1. ^ "Single Drug Information". International Medical Products Price Guide. Retrieved 9 December 2017.
  2. ^ BNF69, page 528

References[edit]

  • British National Formulary : BNF 69 (69 ed.). British Medical Association. 2015. ISBN 9780857111562.
  • British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. ISBN 978-0857112989.
  • British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. ISBN 9780857113382.
  • Hamilton, Richard J. (2011). Tarascon Pharmacopoeia (2011 library ed., 2011 ed., 12th ed.). Sudbury, MA: Jones & Bartlett Learning. ISBN 9781449600679.
  • Hamilton, Richard J. (2013). Tarascon Pocket Pharmacopoeia : delux lab-coat edition (14 ed.). Sudbury,MA: Jones & Bartlett Learning. ISBN 9781449673611.
  • Hamilton, Richard J. (2014). Tarascon Pocket Pharmacopoeia : 2014 deluxe lab-pocket edition (15 ed.). Sudbury, MA: Jones & Bartlett Learning. ISBN 9781284053999.
  • Hamilton, Richard J. (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Sudbury, MA: Jones & Bartlett Learning. ISBN 9781284057560.
  • Hamilton, Richard J. (2016). Tarascon Pharmacopoeia 2016 Professional Desk Reference Edition (6 ed.). Sudbury, MA: Jones & Bartlett Publishers. ISBN 9781284095302.
  • Hamilton, Richard J. (2018). Tarascon Pocket Pharmacopoeia 2019 Deluxe Lab-Coat Edition (20 ed.). Sudbury, MA: Jones & Bartlett Learning. ISBN 978-1-284-16754-2.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Colin/ExistingPrices&oldid=984474521"